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ABSTRACT
The Human Papillomavirus (HPV) is the most common sexually transmitted disease, and
is known to cause genital warts, cervical intraepithelial neoplasia (CIN), and cervical
cancer. HIV-positive women are at greater risk of contracting HPV, experiencing CIN,
having more advanced-grade CIN, and developing cervical cancer due to their
compromised immune status. Since becoming an essential part of women’s preventive
healthcare, the Papanicolaou test, commonly known as the Pap smear, has helped to
reduce cervical cancer incidence and mortality; however, many HIV-positive women do
not meet recommended Pap test screening guidelines. This study addressed the following
research question: What psychosocial, cultural, contextual, and organizational factors
influence HIV-positive women’s engagement in cervical cancer screening? Using a
qualitative grounded theory approach, one-on-one interviews were conducted with 19
HIV-positive, African American women of childbearing age in Shelby County, TN.
Additionally, participants completed a questionnaire to assess demographic and
socioeconomic characteristics, health history, and Pap test screening knowledge. Seven
major themes emerged from the data: General Lack of Knowledge, Benefits Outweigh
Barriers, Limited Role of Social Support, Disconnect Between Health and Religious
Beliefs, HIV as a Facilitator, Reliance on Healthcare Provider, and Intersectionality. The
findings presented here provide insight into what motivates HIV-positive women to
engage in regular Pap test screening as well as how factors across the social ecological
spectrum are related. This information will help public health practitioners to develop
interventions for increasing and preserving cervical cancer screening compliance.
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW
HPV and Pap Test Screening
The Human Papillomavirus (HPV) is the most common sexually transmitted disease
(STD), affecting approximately 25 million Americans, and is known to be the cause of genital
warts, cervical intraepithelial neoplasia (CIN), and cervical cancer (Chin-Hong & Palefsky,
2005; Friedman & Shepeard, 2007). In the United States, cervical cancer is the second most
common gynecologic cancer in women and the tenth leading cause of cancer deaths (Ackerson,
2010; Anderson et al., 2006). Each year since 2010, more than 12,000 new cases of cervical
cancer have been diagnosed in the United States, and at least 4,000 women died of the disease
annually (Benard et al., 2014; Head & Cohen, 2012; Yoo et al., 2017).
The Papanicolaou test, commonly known as the Pap smear, has been an essential part of
women’s preventive healthcare for several decades. Developed in the 1950s, the Pap smear
involves scraping cells from the cervix using a small spatula or brush for placement on a slide
and examination by a pathologist (Callahan & Caughey, 2007). Since its use became widespread,
the Pap smear has helped to reduce cervical cancer mortality by nearly 90% through early
detection of cervical neoplasia, lesions, and other abnormalities (Ackerson, 2011; Callahan &
Caughey, 2007). Incidence of cervical cancer has decreased from 14.8 per 100,000 persons in
1975 to 6.4 per 100,000 persons in 2013 (Nardi, Sandhu, & Selix, 2016). Current guidelines
recommend Pap test screening every three years following the onset of sexual activity for women
ages 21 to 65 years old (Duffett-Leger, Ledourneau, & Croll, 2008; Montgomery, Bloch,
Bhattacharya, & Montgomery, 2010; Moyer, 2012). Women ages 30 to 65 years old should
receive both a Pap test and HPV test, which is similar to a Pap smear except it checks for the
1

presence of HPV rather than cancer, every five years (Benard et al., 2014). Women over the age
of 65 may forego Pap test screening if they have been adequately screened in the past and are not
thought to be high risk (Nardi et al., 2016). However, more frequent testing may be needed for
women in high-risk groups or with abnormal results (Duffett-Leger et al., 2008; Montgomery et
al., 2010; Moyer, 2012).
If a woman’s Pap smear results come back abnormal, identifying the presence of atypical
squamous cells of undetermined significance (ASCUS) with HPV, atypical glandular cells of
undetermined significance (AGUS), low-grade squamous intraepithelial lesions (LSIL), or highgrade squamous intraepithelial lesions (HSIL), follow-up colposcopy is recommended within six
months to determine the severity of proliferation of the abnormal cells (Curry, Sage, Vragovic, &
Stier, 2012; Keller et al., 2012). The colposcopy is a biopsy involving magnification and staining
of the cervical sample to identify lesions and make a more definitive diagnosis (Callahan &
Caughey, 2007). CIN are graded on a I to III scale based on the portion of the cervix with
abnormally developed cells, with CIN I indicating only mild dysplasia, CIN II representing
moderate dysplasia, and CIN III meaning severe dysplasia (Anderson et al., 2006; Callahan &
Caughey 2007). While CIN I should be treated and monitored, CIN II and III are cause for
greater concern since they are thought to be direct precursors to invasive cervical cancer (Badial
et al., 2018; Chin-Hong & Palefsky, 2005).
Some women, including those who are immunocompromised, are at greater risk of
contracting HPV, experiencing CIN, having more advanced-grade CIN, and developing cervical
cancer (Badial et al., 2018; Fletcher, Vidrine, et al., 2014; Liu, Sharm, Tan, & Barnabas, 2018).
The U.S. Department of Health and Human Services (HHS) has estimated women who are
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positive for the Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome
(HIV/AIDS) are at least five times more likely to develop cervical cancer than women in the
general population (Fletcher, Buchberg, et al., 2014; Lambert et al., 2015). Additionally, the
mortality rate from cervical cancer in HIV-positive women is nearly two times higher than that
of HIV-negative women (Liu et al., 2018). Thus, it is especially important for members of such
high-risk groups to receive regular Pap smears. The purpose of this study is to better understand
cervical cancer screening practices among HIV-positive women living in the Mid-South in order
to inform public health interventions that would further promote this type of screening practice.
Women Living with HIV/AIDS
In 2008, women accounted for nearly a quarter of all new HIV/AIDS diagnoses (Hosek,
Brothers, Lemos, & The Adolescent Medicine Trials Network for HIV/AIDS Interventions,
2012). Among women diagnosed with HIV/AIDS, minorities are disproportionately affected by
the disease. African American women have been the fastest growing group to acquire HIV in
recent years (Raiford, Wingood, & DiClemente, 2007). In fact, as recently as 2016, African
American women have accounted for 61% of new HIV diagnoses among all U.S. women,
approximately 16 times higher than the diagnosis rate of white women (Rao, Andrasik, & Lipira,
2018). Women living with HIV/AIDS may face unique challenges from those encountered by
men who have the disease. For instance, one research team discussed stigma with more than 150
women living with HIV/AIDS in New York City and found that, regardless of race, they
believed they were judged more harshly than their male counterparts (Lekas, Siegel, &
Scrimshaw, 2006). The women also felt blamed for acquiring the disease and said they were
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often deemed immoral or irresponsible for certain sexual and drug use behaviors, and minority
women even more so.
Significance
HPV Incidence and Prevalence
HIV-positive women are at greater risk of cervical cancer largely because they are more
likely to acquire HPV and have persistent HPV infections, including with oncogenic HPV
subtypes (Fletcher, Buchberg, et al., 2014; Liu et al., 2018). Although highly active antiretroviral therapy (HAART) has vastly improved survival, transitioning HIV from a terminal
disease to a chronic illness, it has not affected HIV-positive women’s susceptibility to HPV or
cervical cancer (Lambert et al., 2015). To determine how HPV affects HIV-positive women
specifically, several studies have compared rates and outcomes between HIV-positive and HIVnegative women. Ahdieh and colleagues (2001) compared HPV infection in HIV-positive and
HIV-negative women to understand how varying levels of immunosuppression relate to the
natural history of the disease. Participants in this study were recruited from four sites in the
Northeast region of the United States in the mid-1990s, and included almost 900 HIV-positive
and 500 HIV-negative women. Despite reporting fewer sexual partners, HIV-positive women
had consistently higher rates of HPV infection, including being infected with multiple types of
HPV at once, than their HIV-negative counterparts across the study period. By types of infection,
HIV-positive women were 1.8, 2.1, and 2.7 times more likely to be infected with high-risk,
medium-risk, and low-risk types of HPV, respectively, compared to HIV-negative women.
Additionally, there was a positive correlation between immunosuppression and HPV infection,
such that HIV-positive women with higher CD4 counts, indicating less immune deficiency, had
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lower rates of HPV incidence and prevalence than HIV-positive women who were more
immunocompromised.
A similar study described the pathology of HPV and anogenital disease in HIV-positive
women compared to their HIV-negative counterparts (Chin-Hong & Palefsky, 2005). Not only
were HIV-positive women more likely to be infected with HPV, including high-risk types and
multiple strains, than HIV-negative women, but they also had a shorter transformation from CIN
to invasive cervical cancer and at a younger age. Although the study found a negative
relationship between CD4 count and HPV incidence, the association did not hold for the
diagnosis of cervical and other HPV-related cancers. The authors conclude that
immunosuppression is likely related to HPV incidence and prevalence, but not necessarily the
progression to cancer.
One retrospective study compared diagnostic outcomes after abnormal Pap test results
between HIV-positive and HIV-negative women (Curry et al., 2012). Charts were reviewed for
more than 650 HIV-positive and 750 HIV-negative women who received gynecologic care at
Boston Medical Center from 2002 to 2008. HIV-positive women who underwent colposcopy
after an abnormal Pap smear were twice as likely to have results graded at CIN II or III than
HIV-negative women. Overall, the outcomes after colposcopy revealed no CIN diagnosis in
22%, CIN I in 46%, and CIN II or III in 32% of the HIV-positive women, compared to 45%,
34%, and 21%, respectively, in HIV-negative women. These results indicate HIV-positive
women are more likely to be diagnosed with CIN, and advanced-grade CIN, after an abnormal
Pap smear compared to women who are HIV-negative.

5

Since 1994, the Women’s Interagency HIV Study (WIHS), a long-term, multicenter
cohort study, has been assessing the health outcomes of HIV-positive women in the United
States. Massad and colleagues (2014) used this dataset to compare the long-term cumulative risk
for CIN II and CIN III, or worse, following an abnormal Pap smear result between HIV-positive
and HIV-negative women. The study sample included 56% of the women enrolled in the WIHS,
including 1,824 HIV-positive and 472 HIV-negative women, representing those who had an
abnormal Pap test and subsequent colposcopy within twelve months. Initial cytology indicated
HIV-positive women were more likely to present with more severe abnormality, with 72%
having ASCUS, 26% LSIL, and 2% HSIL compared to 88% ASCUS, 11% LSIL, and 2% HSIL
in HIV-negative women. Colposcopy results indicated 21% of HIV-positive women had CIN II
or worse and 9% had CIN III or worse compared to 11% of HIV-negative women with CIN II or
worse and 6% with CIN III or worse. Although the findings were not statistically significant, this
study found HIV-positive women had consistently higher risk, 1.66 times as likely, for CIN II or
CIN III or worse compared to their HIV-negative counterparts.
Some strains of HPV are more aggressive than others, particularly Types 16 and 18,
which together cause approximately three-quarters of cervical cancer (Lambert et al., 2015;
Schlecht et al., 2005). Silverberg and colleagues (2006) examined HPV-16 in both HIV-positive
and high-risk, HIV-negative women by measuring the optical density of the antibodies. Contrary
to other research, no significant differences in infection rates were found between HIV-positive
and HIV-negative women; however, HIV-positive women, especially those who were immune
compromised, were more likely to sustain and have increases in HPV-16 antibodies, which could
mean active replication is occurring more among HIV-positive women. While the findings from
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this study indicate rates of infection with HPV-16, which is one of the high-risk types linked to
cervical cancer, are similar between HIV-positive and HIV-negative women, the continued
presence of and increases in antibodies suggests the infections are at least more persistent among
HIV-positive women.
Another study used data from the WIHS to examine the presence of oncogenic HPV
types among women with normal Pap results at baseline (Keller et al., 2015). Analysis included
1,021 HIV-positive and 518 HIV-negative women. Their results indicate women who were HIVpositive were significantly more likely to test positive for any HPV than those who were HIVnegative, and this finding held true for oncogenic types of HPV as well, with detection in 15% of
HIV-positive women versus 5% of HIV-negative women. More specifically, testing positive for
HPV-16 was associated with a 13 times greater risk of developing CIN III or worse among HIVpositive women with a normal Pap test result at baseline. This study highlights the importance of
continuous, consistent screening among HIV-positive women, regardless of a history of normal
results.
The increased risk for an abnormal Pap test result faced by HIV-positive women is even
present after a hysterectomy. A retrospective study of a cohort of almost 240 HIV-positive
women in Houston who had undergone a benign hysterectomy, meaning the cause was unrelated
to cervical dysplasia or cervical cancer, found that nearly one-third had an abnormal Pap smear
test, with 5% having ASCUS and being HPV-positive, 23.1% having LSIL, and 2.9% having
HSIL (Smeltzer, Yu, Schmeler, & Levison, 2016). These women did not have a history of
abnormal Pap tests, and no demographic risk factor could be identified, indicating HIV-positive
women may still need to engage in screening efforts even following hysterectomy.
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Liu, Sharma, Tan, and Barnabas (2018) provide a recent systematic review of the
literature regarding HIV-positive women’s risk of HPV, precancerous lesions, and cervical
cancer. Their meta-analysis included 38 studies, nearly half of which included HIV-negative
women as a comparison group, and covered the relationships between HIV status and HPV
incidence, HPV persistence, progression to LSIL and HSIL, regression from LSIL and HSIL,
and progression to cervical cancer. All studies found HIV infection to be associated with higher
incidence and perseverance of HPV. Studies showed an inverse relationship between CD4 count
and HPV acquisition, where the risk of contracting HPV increased as CD4 count decreased,
while there was a direct relationship between viral load and risk of HPV infection, meaning one
increased with the other. The relationship between HAART and HPV was unclear. Being HIVpositive was associated with higher incidence of LSIL and HSIL, suggesting immunodeficiency
may especially impact early progression of HPV. Also, women who were HIV-positive were
more likely to have persistent HPV infection and even HPV reactivation, which led to greater
disease progression and cervical cancer.
Treatment Outcomes
The current evidence indicates HIV-positive women are at greater risk of contracting
HPV, being infected with multiple and high-risk types of HPV, as well as experiencing faster
progression to more severe CIN grades and cervical cancer than their HIV-negative counterparts.
In addition to these studies of the natural history of HPV, other researchers have examined
outcomes following surgical excision treatment of CIN, which includes loop electrosurgical
excision procedures (LEEP), laser ablation, or cold-knife conization, in HIV-positive women
(Lodi et al., 2011; Massad et al., 2007). LEEP is the current standard of care for CIN treatment
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and involves removing the affected part of the cervix with a cauterizing wire loop. Laser ablation
is similar to LEEP, but uses a laser instead of a cauterized loop to remove the abnormal cervical
tissue; one benefit of laser ablation is that it is more precise so removes less of the normal cervix.
Before LEEP, cold-knife conization was the standard CIN treatment procedure, in which a
wedge of the affected area of the cervix was cut out and removed (Callahan & Caughey, 2007).
Massad and colleagues (2007) looked at the rates of treatment failure and success based
on CIN grade in HIV-positive and HIV-negative women enrolled in two multi-site, prospective
studies. Initial treatment failure was indicated by the continued presence of CIN six months after
treatment; nearly half of the HIV-positive women in the sample experienced initial treatment
failure, while only one-third of the HIV-negative women did so. Of the women who initially
experienced treatment success, over half eventually experienced reinfection with HPV, and HIVpositive women had a significantly shorter HPV-free time interval than did HIV-negative
women, 30 months versus 70 months, respectively. Interestingly, although HIV-positive women
were more likely to experience subsequent HPV infections after initial treatment, these may
actually represent new, opportunistic infections rather than recurrence of the previous infection.
One study examined correlates of CIN recurrence after conization through LEEP in HIVpositive and HIV-negative women (Lodi et al., 2011). In this case-control study, three-quarters
of HIV-positive women experienced CIN recurrence compared to only one-quarter of HIVnegative women, a rate of more than four times higher. Contrary to the authors’ hypothesis, there
were no differences in CIN recurrence in HIV-positive women based on CD4 count or grade of
the cervical lesion, suggesting that severity of disease may not be the primary risk factor for
recurrence. Additionally, women who experienced glandular involvement, which occurs when
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dysplastic cells deep in the cervix are protected from destruction during treatment, were 11.78
times more likely to experience CIN recurrence. Therefore, glandular involvement was the
greatest risk factor for CIN recurrence after LEEP treatment in all women, but being HIVpositive also increased this risk.
Pap Test Screening
Current Recommendations
As stated previously, current guidelines recommend women engage in Pap test screening
every one to three years beginning at age 21 (Duffett-Leger et al., 2008; Montgomery et al.,
2010; Moyer, 2012). However, because HIV-positive women are at greater risk of both
contracting HPV and suffering its negative consequences, their screening guidelines are more
stringent (Williams, Moneyham, Kempf, Chamot, & Scarinci, 2015). The Ryan White Part A
Program HIV/AIDS Bureau (HAB) oversees the core elements of primary care for people living
with HIV/AIDS (PLWHA) and establishes recommendation guidelines (Health Resources and
Services Administration (HRSA) HAB, 2010). Regarding Pap test screening for HIV-positive
women, the HAB currently recommends two Pap tests during the first year of enrollment with
Ryan White, one at the initial visit and another six months later, with annual screening beginning
in the second year. If an HIV-positive woman has an abnormal Pap smear, follow-up colposcopy
should be completed within six months and another Pap test should be performed in the six
months following that (HRSA HAB, 2008).
Accuracy
The Pap test is an essential part of women’s preventive healthcare used to identify CIN.
While it has often been assumed the Pap test is accurate in all populations of women, one study
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sought to actually test whether the sensitivity and specificity of the test was different for HIVpositive women (Anderson et al., 2006). The participants in this sample included almost 200
HIV-positive and 100 HIV-negative women who were recruited in Baltimore, MD in the mid1990s and enrolled in the study until 1999. In this case, HIV-positive women with a more
compromised immune system, defined as a CD4 count of <500 cells/mm, had greater risks of
false negative results, meaning the incidence of low-grade CIN was not detected despite it being
truly present. However, the overall accuracy of the Pap test was the same in both HIV-positive
and HIV-negative women, being highly sensitive and specific for both populations.
Demographic and Socioeconomic Characteristics
Several studies have sought to identify demographic and socioeconomic covariates
associated with Pap test screening in HIV-positive women. One such study examined
prospective screening behavior in a cross-sectional study with 209 HIV-positive women at a
comprehensive healthcare center in Houston, TX (Ogunwale et al., 2016). More than 85% of the
women adhered to recommended Pap test screening guidelines; these women also tended to have
more clinic visits, were more likely to have their physician recommend a Pap smear to them, and
indicated their partners were supportive of them engaging in Pap test screening. Those who did
not achieve Pap test screening guidelines tended to be younger and report multiple sexual
partners.
Another study retrospectively examined the medical records of HIV-positive women who
were patients at an urban clinic in Boston, MA (Baranoski, Horburgh, Cupples, Aschengrau &
Stier, 2011). In this case, women who were older, Hispanic or White, born in the United States,
unemployed, current or past drug or tobacco users, or who had a baseline CD4 count of <200
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cells/mm were less likely to have received a Pap smear in the previous year. Looking at records
over a period of eighteen months, the authors concluded that most HIV-positive women in this
setting did at least receive occasional Pap smear tests, but not always on an annual basis as
recommended; however, still nearly one-third of the sample did not receive a Pap test at all
during the study period.
In a similar study, retrospective chart reviews were conducted to determine both rates of
initial and follow-up Pap smears in 69 HIV-positive women who received at least one year of
care at a county-based HIV clinic (Rahangdale, Samquist, Yavari, Blumenthal & Israelski,
2010). Over a four-year period, more than three-quarters of the participants received at least one
Pap smear. Two-thirds of the women had normal results from this initial Pap test, but of these,
only 60% received a second Pap smear within the next 18 months. For the one-third of the
sample who had abnormal results from the initial Pap test, 51% were identified as ASCUS1, 36%
were LSIL2, 10% were HSIL3, and less than 2% were AGUS4. Only 62% of these women had a
follow-up Pap smear within one year. Also, HIV-positive women who had ever had a CD4 count
<200 cells/mm were less likely to engage in Pap test screening at all, which may reflect their
overall engagement in care.
Yet another study involved the random selection of 200 HIV-positive women’s medical
records to determine how well patients attending a health department clinic between 2000 and
2006 met the Ryan White Part A Program HAB guidelines for Pap test screening (Logan,

1

ASCUS: Atypical Squamous Cells of Undetermined Significance
LSIL: Low-Grade Squamous Intraepithelial Lesions
3
HSIL: High-Grade Squamous intraepithelial Lesions
4
AGUS: Atypical Glandular Cells of Undetermined Significance
2
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Khambaty, D’Souza & Menezes, 2010). The sample was largely made up of low-income, racial/
ethnic minority women. In their first year of care at the clinic, over 80% of the participants
received at least one Pap smear; however, less than 25% completed the two that are
recommended. Approximately 40% of women with abnormal results on the initial test received a
second Pap smear, while only 20% of those who had normal results on the first Pap test had a
second one. Meeting the Ryan White Part A Program HAB Pap smear guidelines was
significantly associated with having more than just Ryan White coverage as health insurance and
receiving care at one particular clinic within the health department setting. While the rate of
initial Pap test screening was fairly high, the recommended second Pap smear was less complete,
even among those who had abnormal results from the first test.
If a Pap smear returns abnormal results, follow-up appointments for further testing
through colposcopy are needed, especially for HIV-positive women who are at greater risk of
developing CIN. However, rates of attendance for follow-up care are often lower than those for
initial screening, resulting in delayed diagnosis and treatment of infections or cervical cancer
(Abercrombie, 2003). Baranoski and Stier (2012) conducted a retrospective study to identify
independent variables associated with time between receiving an abnormal Pap test result and
attending a follow-up appointment in 177 HIV-positive women. Overall, only 59% of
participants received a colposcopy within 6 months of receiving their initial Pap test results.
Variables associated with decreased time between initial and follow-up appointments included
higher grade CIN on the abnormality index of Pap test results, seeing the HIV clinic nurse
practitioner versus an outside gynecologist for the initial Pap test, having a CD4 count >500
cells/mm, being married, and having private insurance. At one year from the initial Pap smear,
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still only 68% of the women with an abnormal Pap test result had attended a follow-up
appointment, with no changes in covariates being identified. While it is promising that more than
two-thirds of the sample received a colposcopy within a year of their initial Pap test and that
women with higher grade CIN tended to receive follow-up care earlier, 14% of women with high
grade CIN and one-third of women with low grade CIN did not attend a follow-up appointment
within a year of receiving an abnormal Pap test result.
Psychosocial Influences
Psychosocial factors concentrate on the beliefs and perceptions which affect individual
health behaviors and lifestyle choices. Stokols (1996) offers three forms of influence at the
intrapersonal level: Cognitive, which involves a person’s beliefs and opinions, Affective, or a
person’s evaluation of something, and Behavioral Modification, or changes in a person’s actions.
These are often simplified and packaged together as Knowledge, Attitudes, and Beliefs. Public
health researchers examine psychosocial influences of health to identify them, determine their
source, understand their role in decision-making, and develop interventions to modify them in
hopes of promoting better health. For Pap screening, like other preventive health behaviors,
researchers are interested in learning what women know about Pap smears, HPV, and cervical
cancer as well as why they do or do not comply with recommended guidelines, and how public
health practitioners might be able to affect these decisions.
Knowledge. Although many women acknowledge Pap smears as a basic part of
women’s healthcare, they may lack even a basic understanding of what it is for, the examination
itself, and what the results mean (Breitkopf, Pearson, & Breitkopf, 2005). Seeking to understand
knowledge of Pap test screening among women with low socioeconomic status, one group of
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researchers developed and assessed their own measure (Breitkopf et al, 2005). More than 300
women completed the 20 True-False question knowledge survey between 2002 and 2003, which
covered the topics of Pap screening purpose, symptoms of an abnormal Pap smear, what to do if
a Pap test result is abnormal, and what follow-up after an abnormal Pap test involves. The
sample population was evenly split between White (34.3%), Black (34.0%), and Hispanic
(31.7%) women; more than two-thirds were unmarried, approximately 60% had less than a high
school education, and nearly half had a household income of less than $10,000 per year. Several
women answered the questions about the purpose of a Pap smear incorrectly; for instance, 61.2%
said the purpose was to check ovaries and 73.1% said it was to test for sexual disease. However,
more than 85% correctly answered the purpose of a Pap smear is to scrape cells to look for
cancer. Only slightly more than half correctly answered unnoticeable or no symptoms (50.9%)
and unusual vaginal spotting or bleeding (58.9) were possible symptoms of an abnormal Pap
smear, and only 42% accurately identified genital warts as a possible symptom of an abnormal
Pap smear. The majority of the women knew they should tell their partner (89.3%) and may need
more frequent Pap smears (75.1%) if they had an abnormal Pap test result, and more than twothirds knew an abnormal result did not necessarily mean cancer. However, only slightly more
than 10% correctly stated the problem could go away on its own. Answers regarding follow-up
after an abnormal Pap smear were wide-ranging; while more than 85% correctly said another Pap
smear test would be needed, only 21.6% knew colposcopy as an option. Overall, the women in
this study had relatively low knowledge of Pap smears.
Daley and colleagues (2013) assessed knowledge of Pap test screening among three highrisk populations at various points in time: HPV-positive women prior to the development of the
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HPV vaccine, college women after the development of the HPV vaccine, and minority college
women after the development of the HPV vaccine. The primary outcome variable was measured
by a single question: What is the Pap smear a test for? Participants selected Agree/Disagree or
True/False for 8 sexually-related outcomes: pregnancy, HIV/AIDS, herpes, gonorrhea, HPV,
cervical cancer, yeast infections, and vaginal infections. Across all three samples, the majority
(75% - 84%) correctly indicated a Pap smear tested for cervical cancer. However, a large number
answered incorrectly for HPV (82% - 91%), vaginal infections (76% - 92%), yeast infections
(65% - 86%), gonorrhea (55% - 81%), and herpes (53% - 80%). Fewer participants believed the
Pap smear tests for HIV/AIDS (22% - 59%) and pregnancy (17% - 38%). While most of the
women did know the purpose of a Pap smear is to test for cervical cancer, they incorrectly
thought it tested for other issues as well.
One recent meta-analysis found few articles, only 17 overall with 9 in the United States,
studied HIV-positive women’s knowledge of HPV and cervical cancer screening, but those that
did reported relatively low knowledge regardless of region or country (Wong et al., 2018). Some
women had never heard of HPV, while others did not know how it was transmitted or about its
relationship to cervical cancer. Most women in these studies knew they should have regular Pap
smears, but were unaware of the specific guidelines for HIV-positive women. There was also a
lack of understanding of the role HIV plays in susceptibility and severity of HPV and cervical
cancer. While some of the women assumed they might be at greater risk simply because having
HIV lowers their immune system, others thought lack of symptoms, sexual activity, or family
history meant they were safe. The role of health literacy varied, with some studies finding it to be
significantly related to knowledge and others finding no such association.

16

Knowledge related to cervical cancer screening can not only affect engagement in regular
Pap testing, but also follow-up care if a Pap smear result comes back as abnormal. Sharpe,
Brandt, and McCree (2006) interviewed 44 women in South Carolina who had received an
abnormal Pap smear in the previous five years to understand their knowledge and beliefs about
their results. First, the participants answered True-False questions about HPV; the vast majority,
80%, knew some types of HPV were related to cervical cancer, while only 15% knew HPV was
the most common STD. During the one-on-one interviews, seven key themes emerged: 1.) The
association between an abnormal Pap smear and developing cancer, 2.) The need for more Pap
screening, 3.) The need for other additional tests or procedures 4.) Having a low level of concern
initially, 5.) Explanations for the abnormal result; 6.) An association between the abnormal result
and sexual activity, and 7.) The association between the abnormal Pap test result and HPV or
other STDs. Although more than three-quarters of the women discussed the link between an
abnormal Pap smear result and developing cancer, less than half named cervical cancer
specifically and some were confused about whether or not they already had cancer. Nearly all of
the women understood they would need to have repeat and more frequent Pap smears as well as
other tests and procedures. The women seemed relatively unphased by their abnormal Pap test
result, and this was largely attributed to the apparent lack of concern by their healthcare provider.
The women in this study had experienced an abnormal Pap test result and possessed a basic
understanding of the implications as such, but still lacked detailed knowledge of HPV and
cervical cancer.
Beliefs. A study of more than 300 HIV-positive women in Florida sought to compare
the relationships between knowledge, self-efficacy, and the constructs of the Health Belief

17

Model (HBM), which are Perceived Benefits, Barriers, Severity, Susceptibility, and Cues to
Action, and their ability to predict having a Pap smear in the last year (Lambert et al., 2015). The
participants were recruited from two local clinics and completed surveys with Likert-scale and
multiple-choice questions. Higher knowledge was associated with increased self-efficacy and
benefits, while lower knowledge was associated with more perceived barriers. As perceived
severity increased, so did perceived susceptibility, benefits, and barriers. There was a strong
relationship between self-efficacy and benefits, but only a weak correlation between
susceptibility and barriers. Women who had a Pap test in the last year had fewer perceived
barriers and more self-efficacy than those whose last Pap smear was more than a year prior.
However, no significant differences in time since last Pap smear were found based on
knowledge, susceptibility, severity, or benefits.
Using a mixed methods approach, Tello and colleagues (2010) studied covariates and
barriers to attending gynecological appointments and receiving annual Pap smears among HIVpositive women obtaining care at a Baltimore, MD clinic. Overall, 69% of the 200 participants
missed a gynecological appointment and 22% had not received a Pap smear in the last year.
When only those women with a cervix were considered, moderate to severe depressive
symptoms were associated with both missing a gynecological appointment and not receiving a
Pap smear. Other factors associated with not having a Pap test included completing less than a
high school education, being older in age, and having a higher viral load. For African American
women, having moderate to severe depression was associated with both missing a gynecological
appointment and not having a Pap test in the last year. Also, drug use was associated with
missing a gynecological appointment, and having a lower education was associated with not
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receiving an annual Pap test. Using focus group discussions, barriers to attending gynecological
appointments, including for annual Pap testing, were identified by participants; these barriers
included fears of discomfort from the procedure, receiving bad news from the examination,
simply forgetting about the appointment, and being sick or experiencing bad weather on the day
of the appointment.
An important topic in the last decade related to cervical cancer screening is the HPV
vaccine. Several studies have assessed knowledge and beliefs about HPV in relation to vaccine
acceptability and uptake, both in young adults and in parents. One such study conducted in rural
North Carolina compared HPV beliefs and vaccine acceptability among African American and
Caucasian mothers (Cates, Brewer, Fazekas, Mitchell, & Smith, 2009). Nearly 100 Black and 50
White mothers participated in the study, and the majority were considered middle class, with at
least a high school education, a full-time job, and health insurance benefits. Less than onequarter of Black women, compared to nearly 60% of White women, had ever heard of HPV, and
Black women scored significantly lower on the knowledge test. Fewer Black women believed
they or their daughters were at risk for developing cervical cancer compared to the White
participants. Despite these differences, beliefs about and acceptability of the HPV vaccine were
relatively similar in both races. Only 20% of all participants had ever heard of the HPV vaccine,
and all had moderate views of its safety and efficacy. However, Black mothers had less intention
of vaccinating themselves or their daughters than did White mothers.
Sociocultural Factors
Culture is a shared system of values, beliefs, behaviors, social patterns, and other
customs, and has a significant impact, whether consciously or subconsciously, on an individual’s
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health (Steele-Moses et al., 2009). Humans are social creatures; as such, social networks
significantly influence social identity (McLeroy, Bibeau, Steckler, & Glanz, 1988). An
individual’s social network describes their system of interpersonal relationships and social
support, both their characteristics and functions (Heaney & Israel, 2008). Social interactions,
shaped by society and culture, figure into an illness experience through relationships and
interactions with others and become a central part of the experience of suffering (Miles, Isler,
Banks, Sengupta, & Corbie-Smith, 2011). Thus, interpersonal relationships, whether formal or
informal, with family and friends or professional contacts and acquaintances, shape health beliefs
and behaviors.
Social Network. Much of the social network research on cervical cancer screening
concentrates on marital status and relationships with significant others. One such study, using
data from the 2012 Behavioral Risk Factor Surveillance System (BRFSS) survey, found married
women were significantly more likely than never married and separated, divorced, or widowed
women to engage in cervical, breast, and colorectal cancer screenings, with rates of 83.9% versus
78.7% and 75.1%, respectively (Hanske et al., 2016). These findings appear consistent with other
literature indicating married people have better screening rates and cancer morbidity and
mortality than unmarried people (Aizer et al., 2013; Saghari, Ghamsary, Marie-Mitchell, Oda &
Morgan, 2015).
However, other research shows significant others may actually hinder women’s
engagement in cervical cancer screening, particularly within certain cultures. For instance, using
the Witness Project as a model, which is generally thought of as successful, Erwin and
colleagues (2007) conducted thirteen focus groups with more than 100 Latina women in both

20

New York City and Arkansas. One of the major themes expressed by the women in discussing
cervical cancer screening was the issue of gender roles. Many of the women said their husbands
were not supportive or even disapproved of them getting Pap smears, as demonstrated through
this representative quote:
“Our husbands don’t understand anything about women’s health and sometimes it gets to
the point that they even get jealous or upset if the wife has a gynecologist appointment.
And the first thing the husband will ask her is not how the physician’s appointment went,
but did a man or a woman physician see you” (p. 373).
The authors’ conclusions suggested including men in educational interventions might be helpful
in changing these detrimental views.
A meta-analysis of violence against women and its impact on cervical cancer screening
found only 8 articles covering the topic between 2002 and 2013 (Leite, Amorim, Primo, &
Gigante, 2016). Seven of the studies were conducted in the United States and the other was done
in Australia, and sample sizes ranged from 100 to 30,000. No significant relationship between
intimate partner violence and Pap test screening was identified in three of the studies, although
one did find an association within the p < 0.10 threshold (p = 0.062). The remaining studies
showed significant associations between violence and Pap screening, but the nature of these
relationships was inconclusive. In two studies, experiencing intimate partner violence increased a
woman’s likelihood of having a current Pap smear, while the others showed a negative
correlation. Another study found women with a history of emotionally abusive relationships
were 87% less likely to have a Pap smear than other women, another study showed women who
had been sexually abused as children were less likely to be screened, and the last found women
who had experienced physical abuse were 70% more likely to not follow up after an abnormal
Pap smear result. The findings in this meta-analysis prove violence against women can impact
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engagement in cervical cancer screening, but the relationship is complex and not straightforward.
Another issue affecting this may be access to healthcare, but it is difficult to distinguish if access
is limited because of intimate partner violence or if access is already limited due to
socioeconomic status but is made worse by such violence.
Social Support. Like social network characteristics, social support comes in a variety of
forms, from tangible, emotional, and informational support (Cohen, Mermelstein, Kamarck, &
Hoberman, 1985) to received versus perceived (Dukel-Schetter & Skokan, 1990), and from both
formal, such as healthcare providers, and informal, including family and friends, sources
(Heaney & Israel, 2008). The role of social support and its impact on quality of life for PLWHA
is well-studied. Communities may avoid the topic of HIV, possibly in an effort to deny its
existence so close to home, express negative views about HIV, or even openly discriminate
against PLWHA (Miles et al., 2011). A study in the rural South found these behaviors were a
heavy burden for PLWHA, as they felt isolated from their social networks and lonely from
carrying such a burden on their own (Miles et al., 2011).
Social support has been shown to help minimize stress, depression, and other negative
effects associated with HIV-related stigma (Vyavaharkar et al., 2010). In their study of 340 HIVpositive African American women living in North Carolina, South Carolina, and Alabama,
Vyavaharkar and colleagues (2010) found social support had a significant, negative relationship
with depression, while stigma was positively correlated with depression. Specifically, women
who believed social support was available to them, who reported multiple sources of support,
and who were satisfied with the support they received were less likely to be depressed.
Conversely, those who felt more isolated and stigmatized were more likely to experience
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depression. A separate intervention used support groups to help HIV-positive, African American
women cope with stigma (Rao et al., 2018). In this case, not only did increasing social support
help reduce the stress and depression associated with stigma, but these changes were also linked
to decreases in viral load.
The role of social support in cancer screening is less clear; while some studies have
shown aspects of social support to be positively related to Pap test screening (Gamarra, Paz, &
Griep, 2009; Silva, Griep, & Rotenberg, 2009), others have found no connection between the
two (Kang, Bloom, & Romano, 1994; Silva et al., 2009). A study of more than 2,100 nonHispanic White and Hispanic Black women in Allegheny County, which encompasses Pittsburg,
PA, determined social support and higher education were significantly associated with having a
current Pap smear (Documet et al., 2015). Additionally, the interaction between social support
and education was such that social support moderated the relationship between Pap test
screening and education, meaning social support was more important for maintaining Pap test
compliance among those with lower education. Based on their findings and other literature, the
researchers offer three reasons for social support having a protective health effect. First, social
support serves as a buffer and coping mechanism for stress. Second, social relationships
encourage screening compliance through knowledge sharing, social norms, and peer pressure.
Lastly, social support could compensate for educational, financial, and emotional barriers by
increasing social capital.
A qualitative study of 20 HIV-positive, African American women in Alabama, 11 of
whom had a Pap smear in the last year and 9 of whom had not, were interviewed about Cultural
Empowerment as well as Relationships and Expectations (Williams et al., 2015). The main
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enabling factor was the sex of the healthcare provider performing the Pap smear; some
participants were not bothered one way or the other, while others felt embarrassment or
concerned about partner jealousy. Some of the women reported nurturing relationships with
family and friends who encouraged the women to take care of their health, and the women were
also motivated to keep up with their health to spend more time with their family. Conversely,
other women, especially those who did not have a current Pap smear, said their family and
friends did not discuss Pap smears with them, and many expressed concern of stigma and
discrimination. These findings affirm the inconclusive, complex relationship between social
support and cervical cancer screening.
Religiosity. Religion can be described as a formal system of beliefs and practices or an
outward expression of worship, and is generally measured by importance, attendance of religious
ceremonies, and belief in God and prayer (Szaflarski, 2013). On the other hand, spirituality is
more the internal, personal belief and connection with God, and is assessed by peace and comfort
derived from faith, coping, and spiritual well-being (Szaflarski, 2013). The concepts of religion
and spirituality are distinct, but nonetheless overlapping, and both are complex (Szaflarski,
2013). Spirituality, whether formal or informal, may improve coping and increase resilience by
providing a sense of purpose, reason for living, or belief in second chances (Rao et al., 2018).
Historically, the church has been more than a worship center for African Americans, providing
resources and support for the community (Holt, Roth, Huang, Park, & Clark, 2017; Prado et al.,
2004). Spirituality plays a significant role in the mental and emotional well-being of HIVpositive, African American women, serving as a source of guidance, comfort, peace, and
protection (Dalmida, Holstad, Dilorio, & Laderman, 2012). A review of the literature on the role
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of religion and spirituality among PLWHA revealed several themes, including religion as a
source of support, spirituality as a barrier or facilitator to treatment, personal faith as a coping
strategy, and spirituality in palliative AIDS care (Szaflarski, 2013).
A study of 20 HIV-positive, African American women in the Atlanta metropolitan area
used focus groups to assess the women’s meaning and use of spirituality (Dalmida et al., 2012).
Nearly all of the women, 95%, considered spirituality as “very” or “extremely” important to
them. Three main themes emerged: Spirituality as a process, journey, and connection to a higher
power, Expressions of spirituality, and Benefits of spirituality or a relationship with God. In
describing their spiritual journey, many of the women discussed how their spiritual beliefs and
practices changed as a result of their HIV diagnosis, bringing them closer to God. Church played
a central role in the women’s lives and was their main expression of their spiritual beliefs.
Praying, helping others, and sharing their testimony were other ways the women conveyed their
faith. Many of the participants described God as a healer, and attributed improvements in their
health with incorporating their spirituality in the care they receive from medical providers.
Several of the women said their beliefs provided them with inner peace, support and strength,
and a purpose for living. Most of the women had grown up in church and, as such, identified it as
a part of their culture, but going through the stress of an HIV diagnosis renewed their
relationship with God. Thus, spirituality was a positive influence on the women’s mental and
physical health and well-being.
One prospective study examined the influence of religiosity on medication adherence
among 350 PLWHA in San Diego, CA (Vyas, Limneos, Qin, & Mathews, 2014). Being
affiliated with a religious institution was significantly and positively associated with at least 90%
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adherence with HAART. Exploring further, it was found participants who said their beliefs gave
their lives meaning, connected them with a higher being, helped with their recovery, and helped
them feel connected to humanity were significantly more likely to achieve greater than or equal
to 90% adherence. However, those who believed God created all of the universe and God would
not turn away from them as well as those who attended religious services, participated in rituals,
and prayed to communicate with God were significantly less likely to reach 90% adherence.
While some of the findings from this research were expected, such as religion providing a sense
of purpose and offering hope, this study also found religious coping to be a predictor of
medication adherence. However, when religious beliefs turned fatalistic, meaning they trusted
God had total control regardless of their own actions and behaviors, medication adherence was
poor.
The precise coping mechanisms through which religious beliefs affect health outcomes is
less established. Prado and colleagues (2004) sought to inspect the nature of the relationship
between religious beliefs and coping with stress in a sample of more than 250 HIV-positive,
African American mothers in Florida. Three types of coping were examined: Active, which
involves facing the stressor directly, Support, when help is sought to address a problem, and
Avoidance, where there is an attempt to evade or ignore the issue. In this case, religious
involvement was significantly, positively associated with stress and significantly, negatively
associated with psychological distress; however, religious involvement did not mediate the
relationship between stress and psychological distress. Participants who experienced more
stressors were more likely to be religiously involved, but the more psychological distress a
mother faced, the less likely she was to participate in religion. As for specific coping
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mechanisms, religious involvement was positively associated with social support, active coping,
and support coping, but negatively related to avoidant coping. Thus, mothers who participated in
organized religious activities perceived greater social support and responded to stress with active
and support coping strategies rather than avoidance.
Hotz (2015) studied the link between religion and medical fatalism among twenty-one
African American women with diabetes who were enrolled in a healthy living class at a local
clinic in Memphis, TN, where the present study also took place. Using qualitative interviews, she
identified three overlapping facets: Belief that “not claiming” a disease keeps it from entering the
body, Faith-based clinics helped restore relationships with marginalized communities, and
Provider understanding of social nuances influences the meaning of compliance. Many of the
women responded to diagnoses by stating “I don’t claim that” (p. 2215). While it might sound
like simple denial, the participants explained that claiming a diagnosis is accepting it, taking
ownership of it, and essentially giving in to it. However, it was acknowledged that sometimes
lack of claim does lead to lack of treatment, but not for them personally, as evidenced by their
participation in a healthy living program. Not only are many African Americans distrusting of
the medical system, but some congregational leaders equate seeking health care with lack of
faith, which further deepens the issue. A compromise the women used was seeking care from a
faith-based health clinic, which kept them actively engaged in their own health versus accepting
fatalism. Compliance is another concept that is often over-simplified, and Hotz offers vignettes
to demonstrate this issue. For example, one participant worked three jobs, but planned to
decrease to two once she paid off some debt. In the meantime, she had less flexibility in her
schedule to attend appointments and take medication at the appropriate time, even though her
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health was important to her. In these situations, non-compliance does not stem from a lack of
understanding or unwillingness to follow doctor’s orders, but rather from circumstances beyond
the patient’s control, a truer form of fatalism.
The literature on the impact of religious beliefs on cervical cancer screening practices is
limited; however, one study did look at religious affiliation, family structure, defined as
traditional or non-traditional, and HPV high-risk and protective practices among college-aged
women (Wigfall et al., 2012). More than three-quarters of the 467 participants identified
themselves as religious, most affiliating as protestant Christians. Nearly 93% of the women had
engaged in sexual intercourse, more than 70% before the age of 18, with an average of three to
four partners. There was a significant relationship between religious affiliation, family structure,
and condom usage, which was considered a protective behavior. Participants raised in a
traditional family structure who identified as religious were more likely to use condoms. Highrisk behaviors were categorized as sexual, mainly number of partners, or substance use, smoking
cigarettes or marijuana and drinking alcohol; religious affiliation was only associated with
smoking marijuana. This study found relatively no difference in sexual activity and substance
use between religious and non-religious college women; however, religious college women who
had been raised in a traditional family structure were significantly more likely to use condoms as
a protective measure. Although they may use safe-sex measures, such as condoms, religious
young women were as sexually active as their non-religious counterparts, which still puts them at
risk for contracting HPV and developing CIN or cervical cancer.
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Contextual Considerations
Living with HIV/AIDS. The HIV landscape has changed since the advent of HAART in
1996, becoming a chronic illness more than a terminal disease (Baumgartner & David, 2009).
Still, being diagnosed with HIV can be a traumatic experience, filled with shock, disbelief, guilt,
shame, worry, etc. (Miles et al., 2011). Following up on an initial study conducted with PLWHA
diagnosed before 1995, Baumgartner and David (2009) sought to understand the process of
integrating being HIV-positive into self-identity by talking with individuals who had been
diagnosed after HAART became widespread. In their latest study, three general steps to the
process were identified: Diagnosis, Post-Diagnosis Turning Point, and Integration. The first
study had two additional steps, Immersion and Post-Immersion Turning Point, as the third and
fourth components. Participants reported feeling shock, fear, denial, sadness, and fatalistic after
their diagnosis. Many had not expected to be diagnosed with HIV and so were in disbelief, while
those who knew they had engaged in risky behavior were more likely to experience fatalism.
Although they knew about HAART, fear of dying and an unrealized future were common.
Others went through a period of denial, where they forgot or avoided thinking about their
diagnosis. Sadness was sometimes experienced immediately after diagnosis, but more often was
a secondary emotion after the initial shock and denial wore off. At some point after their
diagnosis, all of the participants faced a turning point, either from learning more about HIV,
disclosing their status to others, or receiving medical intervention. Integration of HIV into one’s
identity occurred over time as the participants received support from others, both inside and
outside of the HIV community, and educated others on their disease. They also reported their
HIV-positive identity started to imprint on their identities, helping with acceptance and
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immersion. Disclosure of their status occurred in stages as well, starting with significant others,
family, and friends shortly after diagnosis to public disclosure at support groups and more
broadly to selective disclosure as needed.
Accepting being HIV-positive as part of one’s identity is a progressive step that comes
with time, but this balance may be fragile if other stressors come onto the scene. Using case
studies to acquire in-depth descriptions of experiences as presented from their own perspectives,
Aranda-Naranjo, Barini-Garcia, and Pines (2005) offer two illustrations of the complex
psychological, physical, and cultural processes that affect HIV-positive women’s follow-up
gynecologic care after an abnormal Pap smear result. In one case, the woman lived with HIV in
isolation, not telling her family and co-workers or attending support groups, and with constant
fear that someone would find out about her disease. Upon learning of her abnormal Pap result,
she assumed she had cancer and began praying, crying that this is “too much for one person to
take” (p. 89). The other participant described herself as a strong woman, having always been the
responsible one in her family and working to raise her children on her own after leaving an
abusive husband. She was open with her family about her disease, but took great pride in
maintaining her independence. Upon learning of the need for colposcopy, she told the nurse “I
can’t take no more bad news!” (p. 89). While the women in these cases dealt with their HIV
disease very differently, one struggling to cope in isolation while the other seemed strong and
had family support, they both were very stressed about their abnormal Pap test results and what
another diagnosis would mean for them.
Fatalism. Fatalism refers to the belief that health is a matter of destiny or chance,
outside of individual control or influence (Potter, Allen, & Roberto, 2018). As a public health

30

construct, fatalism encompasses beliefs, locus of control, and self-efficacy (Drew & Schoenberg,
2011). While religious fatalism, as discussed previously, assumes what happens is God’s will
and in God’s control, medical fatalism is the belief a diagnosis or health outcome is inevitable
(Hotz, 2015). Marginalized individuals may be more fatalistic because their internal locus of
control may already be diminished (Drew & Schoenberg, 2011).
The Women of Color (WOC) study is a prospective, multi-site project designed to assess
quality of care among minority HIV-positive women in both urban and rural areas of the United
States. Using these data, Eastwood and colleagues (2015) compared barriers to HIV care among
more than 920 participants. The two samples differed demographically on all variables except
age, with significantly more Hispanic, single, and less educated women being represented in
urban areas. In regards to HIV care, urban women were more likely to be transferred to different
providers and to be lost to care, but reported a lower frequency of sporadic care than did their
rural counterparts. Urban women also reported more barriers, including the need for more
information, feeling judged, getting back on track on your own, accepting it, feeling
embarrassed, transportation, financial uncertainty, being too upset to deal with problems, and
worry that nothing will help, than did rural women, and these barriers more greatly affected
them. Interestingly, despite living among larger populations, urban women reported more social
isolation than did rural women, which could be related to instability with finances, housing, and
HIV care. In addition, the barriers urban women experienced related more to stigma and fatalism
compared to the barriers of rural women, leading to more psychological and emotional stress.
Experiencing an abnormal Pap smear and needing additional follow-up care not only
have physical ramifications, but psychological and emotional as well. One study used focus
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groups to better understand how HIV-positive women in San Francisco deal with this news and
the factors that influence their decision if and when to attend a follow-up appointment
(Abercrombie, 2003). Overall, five major themes were described by the participants, including
fear, lack of symptoms, life circumstances, health beliefs, and the healthcare provider. For these
women, fear was multi-faceted, including fear of cancer diagnosis, fear due to confusion or a
lack of understanding of the Pap test and results, fear of the follow-up procedures, and fear of
having another serious diagnosis on top of being HIV-positive. Absence of symptoms made it
easy for some women to ignore the initial abnormal results or decide the follow-up appointment
was not truly necessary since they could not see or feel anything wrong with them. Many of the
women in this sample had other stressors to contend with in their lives, including drug use,
homelessness, or abusive relationships, making it difficult to keep follow-up appointments,
especially with no symptoms causing them noticeable problems. Other women did not see
preventive healthcare services as necessary to staying healthy, and some had an inherent distrust
of Western medicine so were suspicious of the Pap smear results and related procedures. A
woman’s relationship with her healthcare provider was also important; those who felt close with
their doctor, who received follow-up services with their usual doctor, or were introduced to the
referred physician were more likely to attend their follow-up appointments than those who felt
stigmatized, unfamiliar, or disconnected from their healthcare provider. Other factors that
facilitated attendance of the follow-up appointment were feelings of empowerment among the
women and prompts or reminders from the healthcare providers.
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Organizational Dynamics
Healthcare clinics and providers themselves can serve as facilitators or barriers to care,
through their facilities, practices and procedures, and overall culture and atmosphere. When
organizations are able to facilitate access, the health outcomes of patients improves. For instance,
with consistent care and medication adherence, HIV may be suppressed and PLWHA may
achieve an undetectable viral load (Hawk et al., 2017). However, the organization can also serve
as a barrier to care, which harms patients and public health overall. This issue is particularly
salient in rural areas, especially in the South, where many communities have access to fewer
medical, mental health, and social support resources (Miles et al., 2011).
Hawk and colleagues (2017) interviewed patients and providers at a Ryan White Part C
HIV healthcare clinic in Pittsburgh, PA to understand facilitators and barriers to HIV
suppression. Three types of factors related to successful care emerged: Clinic, System, and
Provider. The clinic’s organizational model and processes were designed to minimize barriers
and foster positive relationships. For instance, all patients meet with a medical social worker at
intake to conduct a needs assessment. Additionally, there is a team-based approach to care, so all
patients are assigned to a multidisciplinary panel of providers; this allows for improved
communication and coordinated health management. While providers work in a team to care for
patients, they also strive to develop individualized treatment plans, including strategies for
medication adherence based on patient strengths and needs. The clinic also offers ancillary
services, including mental health counseling and a pharmacy, on site, and they receive funds to
help patients cover the costs of their care. Lastly, providers work from a philosophy of reducing
harm and valuing the patient, which involves patient education, including patients in decision-
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making, and not judging harmful behaviors. Using this model, 86% of patients are this particular
clinic have achieved viral load suppression.
One qualitative study looked at barriers to cervical cancer screening for low-income,
HIV-positive women who had not had a Pap smear in more than five years (Andrasik, Rose,
Pereira, & Antoni, 2008). Based on Anderson’s Behavioral Model of Health Services Use, four
types of barriers were identified: Psychological/ Emotional, Enabling Resources, External
Environmental and Outcome. The Psychological/ Emotional barriers related to the participants’
self-esteem, denial and fear. The women felt they lacked power in their lives and were concerned
with HIV-related stigma. They also worried about how another diagnosis would affect them both
physically and psychologically, which allowed for denial over needing to engage in screening
and preventive care when they were not experiencing any symptoms. External Environmental
barriers were generally related to finances, including being under-insured or having no insurance,
not being able to pay co-pays, and lacking transportation to and from the appointment. Enabling
Resources barriers referred to the participants not having the facilitators and support for getting a
Pap smear. Many of the women felt they had too many other issues to deal with in their lives to
worry about cervical cancer screening, and they also did not have enough information or social
support to overcome this. Outcome barriers related to past experiences with the healthcare
system included dissatisfaction with care, negative interactions with providers, and
embarrassment or discomfort with the Pap smear itself. The participants in this study had not
received a Pap smear in several years, and the reasons they identified were largely based on their
conflicting needs and life stressors as well as challenges they faced within the healthcare system.

34

Intersectionality
The concept of intersectionality describes the complex connections between issues that
are often considered separately. Although this research does not provide a comprehensive review
of intersectionality, it is nevertheless important to consider. Rao, Andrasik, and Lipira (2018)
note that HIV research often considers the issues of race, gender, and socioeconomic status
separately rather than as interrelated issues, which may be especially detrimental to
understanding the impact of the disease on African American women. HIV-positive African
American women may face stigma based on multiple of their social identities, including their
HIV status, being of minority race, being a woman, risk factors associated with HIV, such as
drug use or sexual behavior, and socioeconomic status, which encompasses education, income,
history of incarceration, etc. (Rao et al., 2018). Minority women, regardless of their HIV status,
have likely been devalued by society related to other challenges, such as poverty, homelessness,
low education, intimate partner violence, physical or mental health problems, substance abuse,
etc.; thus, stigma related to being HIV-positive is just one more addition (Lekas et al., 2006).
These issues could be even more pronounced in the South, where minorities have faced extreme
discrimination for generations (Miles et al., 2011). In their meta-analysis of HPV and cervical
cancer screening knowledge and disparities among HIV-positive women, Wong and others
(2018) note that having synergistic epidemics, defined as simultaneous diagnoses of commonly
linked diseases, is “not merely concurrent physical diseases; rather, they are health problems that
are exacerbated by historical, sociocultural, economic, and political conditions” (p. e80).
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Theoretical Framework
There are a multitude of factors influencing women’s uptake of Pap test screening;
however, not all are under their control. Acknowledging this, McLeroy, Bibeau, Steckler, and
Glanz (1988) developed the Social Ecological Model (SEM) for health promotion that moves
beyond individually-focused, lifestyle change theories of behavior, which at best are limited in
perspective and at worst may blame the victim. For them, rather, health-related behaviors are not
only affected by, but also affect, society and the environment. Using other ecological models as a
guide, the SEM identifies five levels of influence: intrapersonal, interpersonal, institutional,
community, and public policy. The intrapersonal encompasses individual’s knowledge, attitudes,
and beliefs. The interpersonal deals with formal and informal social processes and networks of
support. Institutions have their own characteristics and organizational culture, such as formal and
informal sets of rules and norms. Community factors describe the relationships between social
networks and organizations within defined boundaries. Public policies are the local, state, and
federal laws that govern society.
Several public health theories address the intrapersonal level, seeking to modify
individual behavior (Stokols, 1996). In regards to screening, including cervical cancer screening,
several studies have used existing public health theories, including the HBM and Theory of
Planned Behavior (TPB) (Lambert et al., 2015). However, the usefulness of this type of research
is limited for several reasons. First, many researchers do not employ the full theory as it was
originally intended. A meta-analysis on the use of the HBM in Pap test screening research from
1984 to 2004 found that no single study had employed the full theory, instead utilizing only one
or two constructs (Tanner-Smith & Brown, 2010). In fact, none of the twelve studies identified
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in this review had examined the Cues to Action construct whatsoever, despite evidence that such
cues may prompt a woman to engage in preventive screenings (Head & Cohen, 2012; TannerSmith & Brown, 2010; Tello et al., 2010).
Second, many of the studies are cross-sectional in design, and, thus, the main outcome of
interest is often intentions rather than actual behavior. For example, Duffett-Leger, Ledourneau,
and Croll (2008) used the TPB to study Pap test screening intentions in a university-based
population of women. Their instrument was a 77-item survey known as the Student Pap Test
Survey, which included measures of the TPB constructs as well as demographic characteristics,
risk factors and knowledge. The results showed Subjective Norms and Perceived Behavioral
Control as well as age at first learning about a Pap test were significantly associated with Pap
screening Intentions. The authors note these findings are similar to other studies, although
Attitudes generally have a stronger relationship than Subjective Norms with Intentions, which
they attribute to their relatively young sample. As informative as this study may be, it
nonetheless faces a limitation fairly common in TPB research: only Intentions are examined.
Thus, it is hard to know how these variables are related to actual cervical cancer screening
behavior in this population.
Lastly, because only items based on preconceived constructs are included, other factors
influencing cervical cancer screening practices may be missed. Qualitative methods are helpful
for addressing this last limitation; however, much of the research employing these types of
methodologies focus their attention on simply identifying facilitators and barriers rather than
explaining how these factors work together to influence cervical cancer screening practices. One
study used focus groups to better understand older women’s Pap test screening behavior
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(Guilfoyle, Franco & Gorin, 2007). Although the HBM was used as a guide, themes were
generated based on the discussions with participants. For instance, although the women
recognized Pap smear testing as a means of early detection, they still viewed cancer as fatal,
unpredictable, and dangerous. Many of the women expressed fatalistic spiritual beliefs in relation
to cancer. In addition, while they recognized every woman as being at risk for cervical cancer,
they felt younger women were more susceptible due to their perceived higher levels of sexual
activity, and thus in greater need of testing. Barriers to screening included aversion to the test
itself, stigma associated with Medicaid insurance, lack of symptoms and previous abnormal test
results or other negative experiences with cancer. While these findings are interesting and
helpful, they merely categorize facilitators and barriers to Pap test screening in this population
rather than considering the meaningful relationships between these factors and how they
influence an older woman’s decisions related to cervical cancer screening.
Grounded theory is a qualitative method that involves the development of a substantive
theory based on participants’ experiences with a particular phenomenon (Draucker, Martsolf,
Ross, & Rusk, 2007). One of the benefits of grounded theory is that the framework and its
constructs are drawn from those with first-hand knowledge of the experience. As Walker and
Myrick (2006) state, “Rather than develop a theory and then systematically seek out evidence to
verify it, researchers using grounded theory set out to gather data and then systematically
develop the theory derived directly from the data” (p.548). To accomplish this, data collection
and analysis are done simultaneously so that initial findings are used to inform future interviews
with participants in order to refine the theory as it emerges.
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Memphis Transitional Grant Area
The Ryan White Memphis Transitional Grant Area (TGA) consists of eight counties in
southwestern Tennessee (Shelby, Tipton and Fayette counties), northern Mississippi (DeSoto,
Marshall, Tate and Tunica counties) and eastern Arkansas (Crittenden county) (Pichon, Morrell,
Digney, Montgomery, & Asemota, 2012). Of the 1.3 million residents in the TGA, 70% live in
Shelby County, TN, which includes the city of Memphis (Pichon et al., 2012). As of 2011, a total
of 7,856 individuals, including those who may not be aware of their status, were believed to be
living with HIV/AIDS in the Memphis TGA, which means the HIV infection rate in this area
(33.7 per 100,000) is three times greater than the national average (10.4 per 100,000) (Pichon et
al., 2012). While the majority of PLWHA in the Memphis TGA are male, approximately onethird are female, with nearly 90% identifying as African American and 60% being in childbearing age (Pichon et al., 2012).
In a recent study using Ryan White data, it was found that only 56% of the nearly 600
women actively engaged in the Part A program in the Memphis TGA received a Pap smear in
2011 (Digney, Morrell, Montgomery, & Pichon, 2013). African American women, women who
resided within Shelby County, TN, and women with four or more medical visits in a twelve
month period were the most likely to have a documented Pap smear. However, it is important to
note that women included in this analysis had all attended at least one medical visit with a Ryan
White provider during 2011, and, as such, the true rate of cervical cancer screening among HIVpositive women in the Memphis TGA may be even lower than what was found in this study.
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Research Question
Although it is known that HIV-positive women are at greater risk of contracting HPV and
developing CIN, many studies only focus on identifying correlates associated with or facilitators
and barriers to Pap test screening. Those that employ a well-known public health theory to guide
their research often consider the intrapersonal level only, and thus find the framework does not
entirely explain women’s actual screening behavior. The purpose of this study is to better
understand the influences, facilitators, and barriers, as well as the relationships among them, to
Pap test screening decisions and behaviors among HIV-positive women in the Mid-South. Based
on this aim, the following research question has been posed:
What psychosocial, cultural, contextual, and organizational factors influence HIVpositive women’s engagement in cervical cancer screening?
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CHAPTER 2: METHODS
Study Design
To answer the aforementioned research question, primary data needed to be obtained
directly from members of the population interest. Additionally, to obtain a fuller understanding
of their experiences, participants needed to be able to share their stories in their own words.
Thus, qualitative research methods were an obvious choice. One-on-one interviews were chosen
over focus groups because of the private nature of the conversations.
This study employed a qualitative methodology, using one-on-one, in-depth interviews to
understand HIV-positive women’s experiences with Pap test screening. A grounded theory
approach was used to gain insight into the facilitators, barriers, and processes of obtaining a Pap
smear for members of this population. As such, data collection and preliminary analysis were
done simultaneously so that early findings could continuously inform data collection in an effort
to uncover the full range of experiences (Corbin & Strauss, 1990; Creswell, 2007). One-on-one,
in-depth interviews are ideal for grounded theory because each participant’s experiences can help
inform the discussion with the next participant to support or challenge the findings and refine the
framework. The interview guide included broad questions to allow participants to describe their
experiences in their own words as well as more specific questions about facilitators and barriers
related to cervical cancer screening. The goal of this exploratory study is to begin to explain the
cervical cancer screening decisions and behaviors of HIV-positive women in the Mid-South, as
well as provide a practical framework for informing future public health interventions to promote
annual Pap test screening in this population.
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Participant Recruitment
Participants in this study were HIV-positive women between the ages of 18 and 45 years
old who identify themselves as African American and speak English. While the target sample
size was set at 30 participants when this study was initiated, the goal of qualitative research is to
reach the point of saturation, when no new data is emerging (Creswell, 2007). Women living
with HIV can be difficult to access. For one, people living with HIV/AIDS may not want to
disclose their status; this may keep them from utilizing available services, even medical care.
Second, members of this population may be transient or face unstable living conditions, making
it difficult to keep in touch with them. Lastly, women are a smaller subset of the HIV
community. With that in mind, identifying and recruiting women for this study relied on
partnerships established in previous work.
Purposive sampling is the deliberate recruitment of participants who can provide the
necessary data to answer the research question (Draucker et al., 2007; Starks & Brown Trinidad,
2007), and was used in cooperation with local HIV organizations and other community agencies
to identify potential participants. The researcher coordinated with one of the largest healthcare
clinics and one of the largest social service agencies who assist the HIV research community to
identify potential participants. The organizations posted flyers, handed out postcards, and even
allowed the research team to spend time in their offices to meet potential participants face-toface and conduct interviews. Additionally, recruitment flyers were distributed to other providers
in the Memphis HIV network via e-mail distribution list. This recruitment flyer included a brief
description of the study and contact information of the researcher; a copy of this flyer can be
found in Appendix A.
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Data Collection
Instruments
Interview Guide. In grounded theory, interview questions revolve around the processes
of a particular experience, including questions of how and why (Creswell, 2007). Using public
health theories to guide research is advisable, but qualitative researchers must also remain
flexible so as not to limit participants’ experiences. The Health Belief Model was chosen as a
basis for the interview guide because it has been commonly used to study screening behaviors,
including Pap smears, and its constructs relate to the research question of this work. The specific
HBM-related questions were based on other interview guides and surveys used in similar studies.
Other questions were also developed from the relevant published literature to address specific
topics, such as spirituality, social support, and sources of information.
For the purposes of this study, the interview guide contained open-ended questions about
psychosocial, cultural, contextual, and organizational influences on the Pap test screening
behaviors of HIV-positive, African American women in Memphis, TN. Psychosocial questions
were largely based on HBM constructs, including Perceived Benefits, Perceived Barriers,
Perceived Susceptibility, Perceived Severity, and Cues to Action. Other questions asked about
social support and sources of information on health matters. Participants were also asked about
how their religious beliefs and spirituality influence their health, and what role, if any, their
church plays. Participants’ experiences with Pap test screening, including the process of making
and attending appointments, interactions with healthcare providers, and understanding the results
of their Pap tests, comprised organizational factors. Additional questions related to having an
abnormal Pap test were asked of participants who indicated they had this experience. Because
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one-on-one interviews are designed to be reflexive and dynamic in nature, the interview guide
contained primary questions as well as potential probes to elicit informative responses from the
participants (Creswell, 2007). The questions asked the women to reflect on their own beliefs and
experiences, but probing questions were sometimes asked in a broader sense if the participants
had little to discuss. Appendix B contains a copy of the interview guide.
Participant Questionnaire. The participant questionnaire contained questions related to
demographic characteristics, socioeconomic status, and health history. In addition, participants’
knowledge was assessed using the Knowledge of Pap Testing Survey (Breitkopf, Pearson, &
Breitkopf, 2005). This particular tool was selected because it was straightforward and short.
Because knowledge was not the primary concern nor was the sample size expected to be large
enough for generalizability, this simple measure met the needs of this study. Breitkopf et al’s
(2005) Knowledge of Pap Testing Survey was developed based on a review of the literature and
findings from qualitative formative research. During pre-testing, Cronbach’s alpha measured
consistency at a fairly good level (α= 0.82), and this was reliable over a three-week period of
time. Internal consistency increased with the study population reported on in the published
manuscript, to a rate of α= 0.88. The survey consists of four subscales: Purpose of a Pap Smear,
Symptoms of HPV, Abnormal Pap Smears, and Follow-Up after Abnormal Pap Smears.
Questions are in True-False format, and higher scores indicate greater knowledge. Given there
may be members of the sample population with limited literacy, the questionnaire was
interviewer-administered for all participants. A copy of the participant questionnaire can be
found in Appendix C.
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Process
Potential participants were recruited directly by a member of the research team or
indirectly by a potential participant contacting the lead investigator via telephone or email with
information found on a recruitment flyer, located in Appendix A. The recruitment flyer was
shared through local community agencies as well as other public forums and email listservs.
Before an interview appointment was scheduled, potential participants were screened using the
tool found in Appendix D to ensure inclusion criteria were met. In addition, the last question on
the eligibility screening tool asked if participants had ever had an abnormal Pap test so the
interviewer could ask additional questions about this experience during the interview session.
Once a participant was deemed eligible for the study, they were given a brief overview of the
project, invited to participate, and an interview was scheduled. Interviews took place in a private
location at a community site convenient for participants, such as an HIV agency or public
library.
Over the course of data collection, four public health students served as interviewers: the
lead researcher, who was a public health doctoral student, and three masters-level public health
students. All interviewers associated with this study completed CITI training and attended an
interview training session held by the lead investigator before collecting data. Interviewers
discussed the study procedures and data collection materials to become familiar with the process
and help standardize participant experiences. In addition, interviewers listened to and read
through transcribed interviews from the study to further understand the process.
At the start of each data collection session, the interviewer provided participants with a
copy of the informed consent form, located in Appendix E, and read it aloud before confirming
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the participant had no further questions and was willing to be involved in the study. Upon
agreeing to be in the study, the participant used their unique identifier, a computer-generated
random number, to sign the form in order to protect their identity while still being able to link
study documents. After informed consent was given, the one-on-one interview discussion began,
generally lasting around forty-five minutes. The interviews were audio-recorded for transcription
and analysis purposes. The interview began with a brief introduction of what a Pap smear is, the
types of questions that would be asked, and a reminder of the voluntary, confidential nature of
the study. The interview guide for the in-depth conversations began with a broad question about
the participant’s overall Pap screening experiences. Next, the questions focused on more specific
aspects of Pap test screening, including facilitators, barriers, the exam process, and the meaning
of results. If the participant indicated they had an abnormal Pap test in the past, a few additional
questions were asked about this experience. A copy of the interview guide can be found in
Appendix B. Although the interview guide provided the basic direction for the discussion, the
conversations were also reflexive to accommodate additional points and probes (Creswell, 2007).
After the one-on-one interviews were finished, participants completed a brief
demographic, health history, and knowledge questionnaire administered by the interviewer. This
questionnaire included items about the participant’s background, such as age, gender, race,
education, income, type of residence, HIV disease status, and Pap test screening history.
Participants also completed Brietkopf et al’s (2005) Knowledge of Pap Testing survey to assess
their knowledge and beliefs. The information gathered from the participant questionnaire helped
inform the context in which the participants live as well as how their knowledge and beliefs fit
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with their cervical cancer screening experiences. Appendix C contains a copy of the participant
questionnaire.
At the conclusion of the interview session, participants were thanked for their
contribution and given a $10 Kroger gift card as compensation for their time and effort. They
also received 2 brochures created by the CDC: one on cervical cancer and the importance of
annual Pap test screening and one on HPV and safe sexual practices, located in Appendices F
and G, respectively. Study-related materials were transported in a locked bag and stored in a
locked file cabinet and on a password-protected computer in a secure office. No names were
included in transcripts or on other documents. Data sources were linked by the participant’s
unique identifier. All materials and procedures were approved by the University of Memphis
Institutional Review Board (IRB protocol #3117).
Data Analysis
In-Depth Interviews
Open Coding. The first step in grounded theory data analysis is open coding, which
entails grouping similar concepts into initial categories (Corbin & Strauss, 1990). Before formal
analysis began, completed transcripts were read through to become more familiar with the
overall content. Experiences and expressed beliefs seeming to be of particular importance were
noted as they emerged across participant discussions, and, where applicable, specific probing
questions were incorporated into future interviews. Memos and notes were used to ensure
consistency throughout this process (Walker & Myrick, 2006). Once all interviews were finished
and transcribed, responses were grouped and inventoried based on the underlying constructs
within the interview guide.
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Axial Coding. The next phase of the analysis process, axial coding, involves the
development of sub-categories and understanding their relationships with each other and higherlevel constructs (Walker & Myrick, 2006). With initial cataloging under corresponding questions
complete, alike responses were put together as themes began to materialize. Context surrounding
participants’ statements was also important in consideration of how themes intersect and interact
with each other.
Selective Coding. Selective coding is the final step in the data analysis process for
grounded theory, and involves unifying the framework under a core concept (Corbin & Strauss,
1990). This central piece begins to materialize as the data and descriptions become thicker
through data collection and analysis. In this final phase, the fundamental story of the
phenomenon is solidified. With the sub-categories and their contexts known, the keynote themes
associated with Pap test screening among HIV-positive women in the Mid-South emerged.
Considering these multi-dimensional factors and their dynamic intersections provides a richer,
more robust account of cervical cancer screening behaviors among this population, informing
public health practitioners as they develop interventions related to these issues.
Participant Questionnaire
The participant questionnaire was used as a supplement to the in-depth interviews to
provide additional contextual information about the participants, such as their demographic
background, socioeconomic status, and health history. The Knowledge of Pap Testing Survey
offered insight into participants’ knowledge of HPV, cervical cancer, and Pap test screening
(Breitkopf et al., 2005). Questions were in a True-False format, and were grouped into four
domains: Purpose of a Pap Smear, Symptoms of an Abnormal Pap Smear, Abnormal Pap Smear
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Results, and Follow-Up Care. Each correct response was coded as a 1, while incorrect and
“Don’t Know” responses were coded as 0; higher scores indicated greater knowledge.
Ethical Considerations
All study-related materials and procedures were approved by the University of Memphis
Institutional Review Board (IRB# 3117). Only minimal risks were associated with this study,
including the discussion of sensitive topics related to HIV, Pap test screening, stigma, etc. To
address this, participants were informed of the voluntary nature of this study and asked only to
share what they felt comfortable discussing. However, a potential benefit of participating in this
study may have been increased motivation to engage in annual Pap test screening by identifying
and discussing specific facilitators and barriers. Additionally, the results of the study will help
inform public health practitioners in planning interventions to increase Pap test screening among
this population.
Given their HIV-positive status, confidentiality was especially important for participants
in this study. As such, interviews were conducted in a private room at a location convenient to
the participant, such as the local library or another community organization. No names were
recorded on any study-related documents, including the informed consent form, participant
questionnaires, and interview transcripts. Instead, participants were assigned a computergenerated random number to use as their unique identifier, protecting their identity while still
allowing for linkage between study documents. Transcripts from the audio recordings also did
not include names of participants or others that may have been mentioned during interviews. All
study-related materials were transported in a locked bag and stored in a locked file cabinet or on
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a password-protected computer kept in a secure location. Compensation for time and effort in the
form of a $10 Kroger gift card and informative brochures was given to all participants.
Credibility
Although different from the quantitative measures of validity and reliability, methods of
rigor in qualitative studies is used to assess trustworthiness (Krefting, 1991). In phenomenology,
the lived experience of the participant is what is being studied, and the researcher must work to
ensure their truth is recorded (Krefting, 1991). Given the participants themselves are experts on
their experiences, analysis for this study was done using their words verbatim. Additionally, the
interviewer summarized and reviewed responses with the participants throughout the interviews
and at the conclusion of the discussions to ensure appropriate interpretation.
Qualitative data should be rich and thick with description, and one way researchers can
hope to ensure this in what they obtain is through prolonged engagement with participants
(Lincoln & Guba, 1985). For this study, allowing the participants to share their truths required
building rapport during the interviews and giving them the freedom to talk; thus, there was no set
length of time for the interview discussions. Additionally, and with neutrality in mind, interviews
were conducted in private, and participants were assured their anonymity and their responses
would be kept confidential.
The interview itself also was designed to increase credibility (Krefting, 1991). The
interview guide followed a logical flow, beginning with a general description of the participant’s
last Pap smear and broadening to other aspects of their life that may influence their engagement
with annual Pap screening. Also, questions were reframed to ask participants about their
individual experiences as well as their thoughts on the experiences of other women. Knowledge
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was assessed not only throughout the interviews, but also through an objective test. During
analysis, the researcher discussed her methods, initial findings, and emerging themes with a
mentor in ensure steps and conclusions were appropriate.
Reflections
Conceptualization
As a graduate assistant, I worked closely with members of the Memphis HIV community
on several research projects, including the 2012 HRSA Ryan White Comprehensive Needs
Assessment. In this capacity, I helped administer surveys to people living with HIV/AIDS,
medical providers, and support service agency employees, and took notes during focus group
discussions. One issue the women brought up was feeling left out and neglected, saying that
research nearly always focused on men who have sex with men or with transgender individuals.
They very much appreciated being included in the Needs Assessment, but felt their specific
needs were often overlooked.
My passion has always been for women’s health, so I knew my doctoral research would
be centered on that area. Specifically, I was interested in breastfeeding, sexual and reproductive
health, and prevention and treatment of women’s cancers. After talking with women living with
HIV/AIDS, I determined to continue working with this population for my dissertation. To
identify a need and develop an appropriate research question, secondary data analysis of
Memphis TGA Ryan White service surveillance was conducted. In narrowing data analysis to
only women, one particular gap in service utilization stood out: Pap screening.
The findings from the formative research study were presented in the previous review of
the literature, but what stood out most was how many women were not being screened, despite
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having access to the care through the Ryan White program. The initial study identified
demographic and socioeconomic correlates to Pap test screening, but hardly shed light on why
some of the women utilizing Ryan White services get Pap smears and others do not. In doing a
preliminary literature review, many studies sought to identify facilitators and barriers to Pap test
screening. Much of the focus was on logistics, what helped get women to their appointments
versus what kept them from making it, but few incorporated multiple levels of the Social
Ecological Model. Additionally, few considered the unique circumstances of HIV-positive
women. Thus, the research questions for this study emerged organically based on formative
research from the existing literature on Pap test screening and with the specific population of
interest: What psychosocial, cultural, contextual, and organizational factors influence HIVpositive women’s engagement in cervical cancer screening?
Study Procedures
Several women were interviewed shortly after recruitment began in the summer of 2014;
these women were highly engaged in care and well-known in the HIV community. However, as
time went on, potential participants lessened and became more challenging to recruit. To help
accommodate schedules, an MPH student working on her practicum was trained to conduct
interviews as well. Participants continued to trickle in, but, as data collection stretched into the
spring of 2015, two additional students were trained to conduct the interviews. All went through
the same training, which involved completing CITI training, reading the study protocol, listening
to and discussing the audio recordings of completed interviews, and reading the verbatim
transcripts, but certainly each interviewer had their own styles and may have asked different
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probing questions. The 19 participants in this study were all recruited over approximately
fourteen months; however, recruitment efforts continued for another year, but to no avail.
As mentioned previously, grounded theory involves simultaneous data collection and
analysis so initial findings from data analysis may be used to inform future interviews. This
technique was utilized for the present study as well; although the main structure and questions
did not change, wording and probes were adjusted as needed. Throughout data collection, I
transcribed and read through the interviews, developing and refining a thematic codebook, and
discussing the process and findings with my mentor. At a certain point, I realized no new themes
were emerging, meaning saturation had been reached, so recruitment ended. After the interviews
were completed, the discussions were transcribed verbatim from the audio recording by the
researcher. However, no specific names of individuals were captured in order to maintain
anonymity and protect confidentiality. Coding in qualitative analysis involves grouping similar
ideas to develop themes and categories (Creswell, 2007). Although there are some variations, the
data analysis process for grounded theory generally involves three types of coding: open, axial
and selective (Corbin & Strauss, 1990). Constant comparison is the key in each of these phases
(Starks & Brown Trinidad, 2007; Walker & Myrick, 2006). To refine the final theoretical
framework, the steps in the data analysis process were reviewed again with all interview
transcripts.
Reflexive Analysis
By the summer of 2015, all of the interviews were completed, and finishing transcriptions
and beginning data analysis was the next step. The lead researcher, myself, had moved out of
state and begun working full-time at a local health department, planning to complete this
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dissertation in the evenings and on weekends. However, those plans became suddenly halted at
the start of the fall semester when I was diagnosed with Stage II breast cancer. Krefting (1991)
describes reflexivity as an “assessment of the influence of the investigator’s own background,
perceptions, and interests on the qualitative research process” (p. 218). A researcher should draw
their conclusions from the data itself, but they must also continuously examine their own
perspectives in collecting and analyzing data (Krefting, 1991). What follows is my own
experience with a serious condition and undesirable treatment; it is meant to exhibit the context
from which analysis was conducted as well as demonstrate the deeper connection I gained from
the results.
Diagnosis. After participating in a mud run, I felt a lump in the shower. My brain
instantly went to breast cancer, but I had a lot of protective factors going for me: I was 30 years
old, healthy and in shape, and did not have a strong family history of breast cancer. I searched
reputable sites on the internet and found comfort that most cases like mine are simply cysts. Still,
I made an appointment at my primary care clinic and the doctor, although confident the lump
was only a cyst, referred me for a mammogram and ultrasound to be on the safe side. My worry
level at that follow-up appointment was minimal; in fact, in an effort to support a fellow graduate
student, I participated in a survey about my mammography appointment and said I was “Not
worried at all” about my results that day. However, my worry increased when the radiologist
wanted to perform a biopsy right then and there.
Since I had never heard of doing a biopsy on a cyst, I asked the radiologist about it, and
was informed the lump was not a cyst but rather a solid mass. This appointment took place on a
Thursday, and the radiologist insisted I come in for the results first thing on the following

54

Monday. I hoped I was overreacting, but nonetheless felt the doctor was indicating the situation
was not good. I finally worked up the courage to ask what, if not a cyst, she thought this was, and
she stated that was what the biopsy was for.
Although I was definitely concerned, I still could not fathom the biopsy would actually
come back as cancer. Not surprisingly then, come Monday morning, when I went in for the
results, I was completely dismayed when it actually did. I knew the old adage of not hearing
anything else after receiving such news, so I was determined to keep it together, ask meaningful
questions, and remember what was being told to me about my treatment plan, which was to
involve chemotherapy, surgery, and radiation; I lasted only a few minutes.
Faith Renewed. Facing a cancer diagnosis and the treatment that comes along with it
was overwhelming. Even with health literacy, social support, adequate insurance and finances, it
was difficult to imagine being able to get through everything, especially with any quality of life.
The situation felt bigger than myself, and thus compelled reliance on a higher power for strength,
comfort, and peace. I had been visiting a church, but began attending regularly and officially
became a member while I was in treatment. I gained additional support from my church family,
emotional in terms of encouragement and concern but also tangible, mostly in the form of food. I
also prayed regularly, giving thanks for good days, venting about bad ones, and asking for help
all along the way. I took comfort in certain Bible verses, particularly Romans 5:3, and would
often repeat them to myself. When I was finally done with treatment and officially declared in
remission, I felt triumphant and strong, but also humble that I had actually been able to get
through it all and still have joy.
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Fatalism. I had been in remission not quite six months when I was diagnosed with a
recurrence. I had been having some sharp pains, but was told it was normal as nerve feeling
came back after surgery and radiation; however, one day at work the shooting pain was enough
to cause a cramp, and that’s when I noticed what felt like a coin slid under my skin. I called my
oncologist and they referred me for an ultrasound to get it checked. The ultrasound was
inconclusive; the mass seemed to have definitive borders, which was a bad sign, but they could
not tell about blood flow. A biopsy was needed to tell if it was malignant or simply scar tissue,
and the results would come in a couple of days. I was nervous, of course; the possibility of
cancer seemed more real this time since it had happened before, but I still could not believe it
actually would be. I tried to rationalize that I had done “the kitchen sink” approach to treatment
the first time around, which my doctors had said gave me a good chance of staying cancer free,
so how could it have come back so quickly?
I got the call two days later with the news that the biopsy had indeed come back as
cancer. Although logically I had known cancer was a potential outcome, I was just as surprised
this time as I had been at the initial diagnosis. Treatment, which once again involved surgery,
radiation, and chemotherapy, was not as scary this time around since I knew more what to
expect, but it was psychologically and emotionally worse. I became depressed and hopeless, it
felt like I would never truly be rid of cancer; I was also anxious, a bit paranoid a new lump or
symptom of metastases would appear any day. I never considered myself a pessimist, but I
definitely felt fatalistic with the recurrence.
Survivorship. It has now been a year and a half since I finished treatment and was
declared to be in remission for a second time. Initially, I was leery of getting back to “normal”
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life, fearing the cancer would come back again just when I was back on track. However, as my
hair grew longer and my energy levels increased, it was clear I could not let fear of cancer
continue to have a hold on me. I am still in care with a psychiatrist to help me accept my “new
normal” and I still get a little bit of “scanxiety” when I am due for follow-up imaging, but
ultimately I feel good about being a cancer survivor.
Analytical Insights. The majority of the analysis for this dissertation was done during
and after my own experiences with cancer, which provided for a unique lens through which to
interpret the results. First, experiencing my own major diagnosis gave me greater insight into the
feelings and concerns women who are diagnosed with HIV might feel. At the same time, I now
know how difficult it is to speculate on how one would feel or how life would change after
another major diagnosis. The stages identified by Baumgartner and David (2009) are all too
familiar, and I realize too that incorporating a major diagnosis into one’s self-identity is not a
linear process. Also, I could certainly empathize with the case studies presented by ArandaNaranjo and colleagues (2005). When facing a recurrence, I worried I would not be able to get
through another diagnosis and more cancer treatment, and I was torn between knowing I had
gotten through it before and feeling greater emotional distress.
Second, I can attest firsthand to the benefits of religion in coping with a crisis. My beliefs
did not lead to religious fatalism, I engaged in standard treatment recommended by my doctor,
but I benefitted from knowing people were praying for me and from having a higher power to
lean to and trust. I also received tangible and emotional support from my church family, in the
form of meals, hospital visits, cards, etc.
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Third, fatalistic beliefs may occur over time, as setbacks and challenges are encountered.
I certainly found this to be true after my recurrence and with trying to get back into a normal life
routine. In a way, it feels like a loss of innocence; I know it is possible to have a life-altering
diagnosis come out of nowhere because I have already experienced it. The difficulty for me has
been not letting the worry and anxiety take over and keep me from enjoying life. The
professional mental health care I have received has provided the most benefit. While I have a lot
of social support through family and friends, I often felt like I was not meeting their timeline for
“moving on”, whether they felt that way or not. My feelings of inadequacy, thinking I was not
living up to others’ expectations, made me feel increasingly isolated and hyper-aware of where I
should be.
The journey to completing this dissertation has been longer and more arduous than I
would have ever imagined. When it started, it seemed simple and straightforward, examining
facilitators and barriers of Pap test screening among HIV-positive women in the Mid-South.
However, the findings from this study as well as the relative published literature demonstrate
how complex these facilitators, barriers, and their relationships with each other really are.
Experiencing a cancer diagnosis firsthand helped me to realize this as well, and gave me a
unique insight for interpreting the results.
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CHAPTER 3: RESULTS
Sample Population
Demographics
A total of 19 women participated in interviews for this study from May 2014 through
May 2015. The women ranged in age from 25 to 45 years old, with the mean age being 35. All of
the women were African American, HIV-positive, and resided in Shelby County, TN. More than
two-thirds of the women were renting the home they lived in, 15% indicated they were staying in
a shelter, 10% were staying with family or friends, and 5% owned their home. When asked their
current relationship status, nearly two-thirds of the women said they were single, just over a
quarter were married or living with their partners, and 10% were separated or divorced. Table 1
details the demographic characteristics of the participants.
Table 1. Demographic Characteristics
Age
25 – 29
30 – 34
35 – 39
40 – 45
Race
African American
County of Residence
Shelby Co, TN
Living Arrangements
I own the home I live in
I rent the home I live in
I am staying with family/ friends
I live in a shelter
Relationship Status
Single
Married/ Living with Partner
Separated/ Divorced
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N
4
4
6
5

%
21.1
21.1
31.5
26.3

19

100

19

100

1
13
2
3

5.3
68.4
10.5
15.8

12
5
2

63.2
26.3
10.5

The majority of the participants had less than a high school education, less than one-third
had attended some college or vocational school, 20% had completed high school or a GED, and
only two participants had completed college or graduate school. Over half of the women
indicated they were unemployed and looking for work, just over 20% were working full-time,
15% were unemployed and not looking for work, one participant was working part-time, and
another indicated she was working as a volunteer. Two of the participants who said they were
unemployed added they were on disability. Two-thirds of the sample population said their annual
household income was less than $10,000, and the average annual income fell somewhere
between $10,000 and $20,000. Nearly three-quarters of the women indicated they receive
TennCare/ Medicaid insurance, four of the women were covered by private health insurance,
three received Medicare, and one said she had no health insurance coverage. Ninety percent of
the participants were enrolled in the Ryan White program. Table 2 provides a summary of
participants’ socioeconomic characteristics.
Table 2. Socioeconomic Characteristics
Education
Less than High School
High School or GED
Some College or Vocational School
College Graduate (Bachelor’s)
Graduate Degree
Employment
Working Full Time
Working Part Time
Unemployed (Looking for Work)
Unemployed (Not Looking for Work)
Other - Volunteering
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N
7
4
6
1
1

%
36.8
21.1
31.6
5.3
5.3

4
1
10
3
1

21.1
5.3
52.6
15.8
5.3

Table 2. Socioeconomic Characteristics Cont’d
Household Income
$0 - $5,000
$5,001 - $10,000
$10,001 - $15,000
$15,001 - $20,000
$20,001 - $30,000
$40,001 - $50,000
Insurance
Private Health Insurance
Medicaid/ TennCare
Medicare
No Insurance
Ryan White Program
Yes
No

N
6
6
1
1
3
1

%
31.6
31.6
5.3
5.3
15.8
5.3

4
14
3
1

21.1
73.7
15.8
5.3

17
2

89.5
10.5

Religion
All of the participants identified themselves as affiliated with a religion. More than twothirds of the women identified as Baptists. Slightly more than 15% said they were nondenominational, 10% said other, and 5% said they were Church of God in Christ (COGIC). The
two women who chose Other elaborated as African Methodist Episcopal (AME) and Pentecostal.
All of the women felt religion was at least a little important in their lives, with the average
between somewhat and very important, and closer to very important. Nearly 85% of the
participants said religion was very important in their life, 10% indicated it was somewhat
important, and 5% said it was a little important. Religious beliefs are detailed in Table 3.
Table 3. Religious Beliefs
What religion do you most identify with?
Baptist
COGIC
Non-Denominational
Other

N
13
1
3
2
61

%
68.4
5.3
15.8
10.5

Table 3. Religious Beliefs Cont’d
How important is religion in your life?
Not important
A little important
Somewhat important
Very important

N
0
1
2
16

%
0
5.3
10.5
84.2

Health and Healthcare
As previously mentioned, being HIV-positive was part of the eligibility criteria for this
study, and all of the participants met this condition. None of the participants were newly
diagnosed with HIV, actually all had lived with their diagnosis for more than 7 years, with the
years since diagnosis ranging from 7 to 38 years (mean = 16.4 years). Only two of the women
had ever been diagnosed with AIDS. Three-quarters of the participants indicated they went to the
doctor immediately after being diagnosed with HIV, and another 10% went within 6 months of
being diagnosed. Only three of the women said they waited more than a year to go to the doctor
after being diagnosed with HIV. Regarding their HIV care now, all of the women indicated they
were actively in care, seeing their doctor between one and four or more times in a twelve-month
period. Over half saw their HIV provider at least 3 times in the past year.
All of the women in this study had gotten a Pap smear done in the last three years, and all
of the women indicated their most recent Pap smear had occurred between 2013 and 2015.
Nearly 85% of the women had ever had an abnormal Pap smear. Fortunately, all of these women
followed up with their doctors within a year of their abnormal Pap smear, with 63% indicating
they followed up immediately and 16% saying they followed up within 6 months. Just under half
of the women had ever been diagnosed with HPV, but only about 20% had been diagnosed with
pre-cancerous cells in their cervix. Slightly more than one-third of the sample had received the
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HPV vaccine. Table 4 describes the participants’ health characteristics as they relate to HIV and
Pap test screening.
Table 4. Health Characteristics
HIV Status
HIV-Positive
Years Since HIV Diagnosis
7 – 10 Years
11 – 15 Years
16 – 20 Years
21 – 25 Years
36 – 40 Years
Ever Diagnosed with AIDS
Yes
No
Time to Follow-Up after HIV Diagnosis
Immediately
Within 6 Months
Longer than 1 Year
HIV Care in the Past 12 Months
1 Time
2 Times
3 Times
4+ Times
Most Recent Pap Smear
2013
2014
2015
Ever Have an Abnormal Pap Smear
Yes
No
Time to Follow-Up after Abnormal Pap Smear
Immediately
Within 6 Months
Within 1 Year
Ever Diagnosed with HPV
Yes
No
Don’t Know
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N
19

%
100

4
6
4
4
1

21.1
31.5
21.1
21.1
5.2

2
17

10.5
89.5

14
2
3

73.7
10.5
15.8

4
2
10
3

21.1
10.5
52.6
15.8

5
12
2

26.3
63.2
10.5

16
3

84.2
15.8

12
3
1

63.2
15.8
5.3

8
10
1

42.1
52.6
5.3

Table 4. Health Characteristics Cont’d
Ever Diagnosed with Pre-Cancerous Cervical
Cells
Yes
No
Don’t Know
Ever Received an HPV Vaccine
Yes
No
Don’t Know

N

%

4
14
1

21.1
73.7
5.3

7
11
1

36.8
57.9
5.3

Knowledge of Pap Testing
As discussed previously, all participants completed Breitkopf et al.’s (2005) Knowledge
of Pap Testing Survey during their interview sessions. The knowledge test covered four topics:
Purpose of the Pap Smear, Symptoms of an Abnormal Pap Smear, Abnormal Pap Smear Results,
and Abnormal Pap Smear Follow-Up Care. Each correct response earned a 1, while incorrect or
unknown responses were given a 0. Higher scores indicated higher knowledge, with a perfect
score being 20; the overall average knowledge score in this sample of women was 12.3.
Purpose of the Pap Smear
Overall, the women were fairly knowledgeable about the purpose of the Pap smear. More
than 40% of the participants got four or five of Purpose-based questions correct. Slightly more
than one-third of the women correctly answered two or three of the statements. Twenty percent
correctly answered only one question or got them all wrong. The average score was 2.84 out of a
possible 5.
More than three-quarters of the women correctly said the purpose of the Pap smear is to
scrape cells to look for cancer and just under three-quarters knew that the purpose is not to test
for sexual disease. Approximately half of the participants correctly said the purpose of the Pap
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smear was not to treat cancer. Forty two percent knew the purpose of the Pap smear was not to
check ovaries. Slightly more than one-third correctly answered that the purpose of the Pap smear
was not to test urine. A detailed breakdown of the Purpose of the Pap Smear sub-scale scores is
provided in Table 5.
Table 5. Purpose of the Pap Smear Sub-Scale
Question (Correct Response)
The purpose of the Pap smear is to…
Check your ovaries (False)
Scrape cells to look for cancer (True)
Treat cancer (False)
Test for sexual disease (False)
Check your urine (False)

Correct N (%)

Incorrect N (%)

8 (42.1)
14 (73.7)
10 (52.6)
15 (78.9)
7 (36.8)

11 (57.9)
5 (26.3)
9 (47.4)
4 (21.1)
12 (63.2)

Symptoms of an Abnormal Pap Smear
As with the purpose of the Pap smear, the women were fairly knowledgeable about the
symptoms of an abnormal Pap smear. Nearly two-thirds of the participants answered at least four
of these questions correctly, and more than 20% answered all six right. More than one-third of
the women got half or fewer of the questions correct, and 10% answered all of the questions
incorrectly. The mean score was 3.68 out of 6.
More than three-quarters of the women correctly stated that unusual vaginal spotting or
bleeding was a symptom of an abnormal Pap smear, and nearly three-quarters indicated that
genital warts were a possible symptom of an abnormal Pap smear. Almost two-thirds of the
participants correctly indicated that both vaginal itch or irritation and pain with sexual
intercourse were not symptoms of an abnormal Pap smear. Less than half of the women were
correct in saying that a frequent need to urinate was not a symptom of an abnormal Pap smear,
and even fewer, slightly more than 40%, correctly indicated that symptoms of an abnormal Pap
65

smear may be unnoticeable or there may be no symptoms. Table 6 shows the knowledge scores
for the Symptoms of an Abnormal Pap Smear sub-scale.
Table 6. Symptoms of an Abnormal Pap Smear Sub-Scale
Question (Correct Response)
Symptoms of an abnormal Pap smear are…
Vaginal itch/ irritation (False)
Pain with sexual intercourse (False)
A frequent need to urinate (False)
Unnoticeable/ no symptoms (True)
Unusual vaginal spotting/ bleeding (True)
Genital warts (True)

Correct N (%)

Incorrect N (%)

12 (63.2)
12 (63.2)
9 (47.4)
8 (42.1)
15 (78.9)
14 (73.7)

7 (36.8)
7 (36.8)
10 (52.6)
11 (57.9)
4 (21.1)
5 (26.3)

Abnormal Pap Smear Results
The women did the worst on answering questions about what to do if a Pap smear result
came back abnormal; none of the women got all of the questions correct. In fact, more than twothirds only got half of the questions right. Slightly more than 20% got three of the four questions
correct, and 10% got one questions correct. The average score was 2.11 out of 4 possible points.
All of the women knew they should tell their partner if they had an abnormal result on a
Pap smear, and nearly 90% correctly indicated more frequent Pap smears may be needed after an
abnormal Pap smear result. However, only 10% correctly answered that an abnormal Pap smear
result does not mean cancer or that the problem could go away on its own. Table 7 describes
participants’ knowledge of abnormal Pap smear results.
Table 7. Abnormal Pap Smear Results Sub-Scale
Question (and Correct Response)
If you have an abnormal result on the Pap
test…
You should tell your partner (True)
It means you have cancer (False)
The problem could go away on its own (True)
You may need more frequent Pap smears (True)
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Correct N (%)

Incorrect N (%)

19 (100)
2 (10.5)
2 (10.5)
17 (89.5)

0 (0)
17 (89.5)
17 (89.5)
2 (10.5)

Abnormal Pap Smear Follow-Up
Knowledge about follow-up after an abnormal Pap smear was fairly high, which may be
related to the fact that many of the women had had abnormal Pap smear results themselves. More
than 40% answered all of the questions correctly, and another quarter only got one question
incorrect. Ten percent of the women got three out of the five questions correct. Slightly more
than 20% of the participants answered only one of the questions correctly or answered none of
the questions correctly. The total points possible was 5, and the mean score was 3.63.
However, each individual question was answered correctly by a fairly high portion of the
participants; in fact, the lowest score still had almost two-thirds of the women answering
correctly. Just less than two-thirds knew that follow-up after an abnormal Pap smear did not
involve blood tests. Slightly more than two-thirds indicated follow-up after an abnormal
involved colposcopy. Nearly three-quarters of the women correctly said follow-up for an
abnormal Pap smear can involve both biopsy and HPV testing. Approximately 85% of the
participants indicated that follow-up after an abnormal Pap smear often involves another Pap
smear. The women’s knowledge of follow-up care after an abnormal Pap smear result is
provided in Table 8.
Table 8. Follow-Up Care Sub-Scale
Question (and Correct Response)
Follow-up for an abnormal Pap smear can
involve…
A blood test (False)
Biopsy (True)
Another Pap smear (True)
Colposcopy (True)
HPV testing (True)
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Correct N (%)

Incorrect N (%)

12 (63.2)
14 (73.7)
16 (84.2)
13 (68.4)
14 (73.7)

7 (36.8)
5 (26.3)
3 (15.8)
6 (31.6)
5 (26.3)

In-Depth Interviews
Health Belief Model
Previous studies have used the HBM as a means of understanding screening behaviors,
including Pap test screening. This study aimed to not be limited to an existing public health
theory, but did use the central constructs of the HBM (Behavioral Perceptions, Perceived Threat,
and Cues to Action) as a starting point for the grounded theory approach. Table 9 summarizes
key points and representative statements based on the HBM constructs.
Table 9. HBM Constructs and Related Responses
Construct
Perceived
Benefit

Theme
Taking Care of One’s Self

Basic Part of Women’s
Health
Knowing What’s Going
On With Your Body

Early Detection

Motivated By Previous
Diagnosis (HIV or
Abnormal Pap Smear)

Perceived
Barriers

Pain and Physical
Discomfort

Representative Statement
“Just, it’s good to get one now, even if I’m not
having sex with anybody, I still feel like I should
go get one, just to be on the safe side.”
[Age 25, Some College]
“Just because it’s something that women should
do.”
[Age 27, Some College]
“I want to know what’s going on down there. I
can’t speak for everybody, but I think everybody
wants to know what’s going on with their own
vagina.”
[Age 36, Less Than High School]
“I think you can know what’s going on with
your body, and, if there’s a chance for cervical
cancer or anything, that maybe they will catch it
early, so they can do whatever they got to do so
it won’t spread or it won’t be as deadly as most
people who don’t take Paps.”
[Age 33, Some College]
“I would rather them do whatever they need to
do so we can figure out why the Pap was
abnormal, as opposed to just walking around
probably having cervical cancer.”
[Age 35, High School Graduate]
“It’s just too painful for me. Like being raped is
what it feels like, somebody is just, like,
invading my privacy and it’s just… nuh uh.”
[Age 25, Some College]
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Table 9. HBM Constructs and Related Responses Cont’d
Perceived
Embarrassing and
“It’s, I mean, of course it’s a little uncomfortable
Barriers
Awkward
because you got somebody you don’t know, you
Cont’d
know, in your private area.”
[Age 41, Less than High School]
Fear of Bad News or
“Just a little bit freaked out because, I don’t
Another Diagnosis
know, no more initials, you know? I got
enough.”
[Age 35, High School Graduate]
Intimidating
“I just hate it. It’s just uncomfortable and I hate
everything, I hate everything about it. I hate the
instruments, I hate sitting up there, I hate the hot
light. I just hate the whole thing.”
[Age 33, Some College]
Not a Priority
“I think the barrier would be, especially in the
African American community, it just really isn’t
of high importance, you know? I think we are
the barriers, I mean, self is the barrier, because
the service is there, it’s accessible.”
[Age 35, High School Graduate]
Few Logistical Barriers
“Transportation, gas is high right now. That is
always an issue, but as far as I’m concerned, I
can always call the number for transportation on
my medical card, so that is not an issue, getting
to the doctor for me.”
[Age 44, High School Graduate]
No Barriers
Um, I don’t, I don’t see any barriers. There’s
nothing hard about getting it.”
[Age 27, Some College]
Perceived
HIV Increases Risk
“In my mind, HIV makes me more vulnerable to
Susceptibility
other things, so now I’m learning to stay on top
of everything.” [Age 35, 2001 HIV Diagnosis,
Previous Abnormal Pap Smear]
Previous Abnormal Pap
“The abnormal pap smear opened my eyes to
Smear
take more, taking better care of myself.” [Age
25, 2011 HIV Diagnosis, Previous Abnormal
Pap Smear]
Not Being Screened
“I mean, the people who will be more at risk are
the women who don’t go to the doctor and get
Pap smears. That is very important, because you
won’t even know if you have HPV or not if you
don’t go get a Pap smear.” [Age 28, 2004 HIV
Diagnosis, Previous Abnormal Pap Smear]
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Table 9. HBM Constructs and Related Responses Cont’d
Perceived
Lifestyle Choices
“They are more at risk if they are, if they’re not
Susceptibility
taking care of themselves as far as eating habits
Cont’d
and smoking, drinking, doing drugs, and things
like that. But then on the other hand, they’re not
at risk if they’re not doing those things,” Age 44,
2006 HIV Diagnosis, No Abnormal Pap Smear
Family History of Cancer “Cancer runs in my family so they check me
extremely careful. If cancer runs in your family,
you’re probably more at higher risk then, you
know, like another.” [Age 41, 1993 HIV
Diagnosis, Previous Abnormal Pap Smear]
Perceived
More Testing after
“They have to get like a biopsy, they have to get
Severity
Abnormal Pap Smear
a colposcopy or something like that.” [Age 28,
Previous Abnormal Pap Smear, Received
Follow-Up Care Immediately]
Early Detection Important “Like I said, from what I’ve heard thus far, the
for Treating Cervical
earlier it’s detected, you know, the earlier they
Cancer
can treat. I think once it’s untreated, then it can
cause other things, even death. It may not be
curable, but it’s treatable.” [Age 35, Previous
Abnormal Pap Smear, Received Follow-Up Care
within 6 Months]
Oncology Treatments
“I think that they either have to have a
(Chemotherapy, Surgery,
hysterectomy or have to get chemotherapy or
Radiation)
will go through those treatments. I don’t
necessarily think cervical cancer, I don’t think, is
the leading cancer that causes women’s death.”
[Age 35, Previous Abnormal Pap Smear,
Received Follow-Up Care Immediately]
Would Handle Cervical
“Really it wouldn’t affect me no more than
Cancer Diagnosis Like
what’s already going on, I just want to make
HIV
sure it’s something that can get treated and don’t
get worse. It would mean I have to get myself
checked more often.” [Age 27, Previous
Abnormal Pap Smear, Received Follow-Up Care
Immediately]
Cervical Cancer Diagnosis “I’d probably be devastated. I’d probably just go
Would Lead to Depression down and just, I already don’t have a lot of
friends, but the few friends I have, my
coworkers, I’d probably quit working and just
stay home.” [Age 25, Previous Abnormal Pap
Smear, Received Follow-Up Care Immediately]
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Table 9. HBM Constructs and Related Responses
Cues to
Healthcare Provider
“Normally the doctor’ll ask me at my visits since
Action
I see her so often, and she’ll be like, ‘Is it time?’
or take a look in my chart, and normally they’ll
tell me when it’s time for my Pap and then do it
there in the office so I don’t have to see a
separate doctor or anything to get my Pap.”
[Age 35, Some College]
Reminder Call from
“One thing that I have noticed with the medical
Doctor’s Office
people, that they have started emailing patients
now about their appointments or they will have
their nurses make calls to the patients to remind
them that they have an appointment.”
[Age 44, High School Graduate]
Personal Calendar
“I usually like to have a visual where I can see
Reminders
my appointment on the calendar or have it in my
cell phone to notify me when it’s time to go to
the doctor.”
[Age 44, High School Graduate]
Certain Time of Year
“Well, for me, I just know that I was diagnosed
with HIV in June so I know around that time of
year I have to get a Pap.”
[Age 33, Some College]
Symptoms
“And then like, if I feel like I’m itching or
burning or something down there, I can just
always walk in the doctor and tell them I need to
see the nurse and then they’ll, I’ll tell them
what’s wrong and then I can get a Pap smear
even when it ain’t time for me to get a Pap
smear.”
[Age 41, Less Than High School]

What psychosocial, cultural, contextual, and organizational factors influence
HIV-positive women’s engagement in cervical cancer screening?
Psychosocial Factors
General Lack of Knowledge. Insights from the interviews largely reflect the findings
from the Knowledge of Pap Testing survey administered with the Participant Questionnaire.
Overall, the women had limited knowledge of Pap smears, often misunderstanding its purpose,
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what it tests for, and what the results mean. “I don’t know if I need the Pap smear or what the
Pap smear does and everything,” [Age 38, Some College]. Several of the women seemed to
equate it with testing for sexually transmitted diseases in general. For instance, one participant
said, “Yeah, so I had to take a Pap, and they take, they called me within three days letting me
that I had gonorrhea, and I knew there was something because when I peed, it was burning,”
[Age 41, Les than High School]. However, this misinformation did not appear to keep the
women from following through with Pap test screening. Although they were not entirely sure
about the purpose of the Pap smear, the participants still saw it as a basic part of women’s health.
Benefits Outweigh Barriers. While they may not have had detailed knowledge about
the purpose of the Pap smear, the participants felt the benefits of Pap smears outweighed the
barriers. The most common barrier, mentioned by 13 of the 19 participants, was pain. One
woman went so far as to compare the pain and physical discomfort of a Pap smear to rape,
saying, “Like being raped is what it feels like, somebody is just like invading my privacy and it’s
just… nuh uh,” [Age 25, Some College].
In addition to physical pain, emotional discomfort was discussed as well, particularly the
embarrassment and awkwardness of having a relative stranger “down there”. Still, although the
women did not enjoy the experience, they felt staying healthy and knowing what is going on
with their bodies was worth the pain. One woman put it this way, “I think I’m more willing to
get one now than I was before, because I hate taking Pap smears, I hate the whole thing, but I
know it’ll help my health and, if something’s going wrong, they’ll find out,” [Age 33, Some
College].
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Another emotional barrier to having a regular Pap smear could be the fear of bad news or
another diagnosis in addition to HIV. This type of fear is not uncommon among people who have
already faced difficult diagnoses, whether HIV, cancer, or a chronic illness. The women in this
study appreciated this issue: “Me, myself, my mind; afraid that it might come out abnormal
would be the reason why, me thinking that there is going to be something wrong would be the
only reason I wouldn’t go get it,” [Age 25, Some College]. However, they also recognized the
importance of early detection if something is found; one participant summed it up this way,
“Well, my feelings about the Pap smear basically is, they are looking for something, to help keep
me healthy, that is the main thing and that is the reason why I go and get it… Benefits to it are
preventative measures, mostly in making sure that everything is intact and the way it needs to be
with the family body, and if anything does come up, it’s caught in time for treatment,” [Age 44,
College Graduate].
Interestingly, few traditional logistical barriers to care were mentioned by participants.
While some acknowledged that transportation could be an issue, they were aware of available
resources to use or, worst case, said they would reschedule. “Transportation, gas is high right
now. That is always an issue, but as far as I’m concerned, I can always call the number for
transportation on my medical care, so that is not an issue, getting to the doctor for me, getting
picked up from the doctor’s office is not an issue as far as transportation is concerned,” [Age 44,
High School Graduate]. A couple of women specifically brought up issues of access related to
insurance and availability, but felt there were enough clinics offering the service to keep it from
being a problem anymore. For the women in this study, maintaining their health, keeping up with
medical care, and early detection of any issues, all of which they saw as benefits to regular Pap
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test screening, were highly important, and overshadowed any physical, mental, or logistical
barriers.
Cultural Influences
Limited Role of Social Support. Most of the women indicated they did not discuss Pap
smears with anyone outside of healthcare professionals, but if they did talk to anyone else, it was
their partner. The reason given for this was that things related to Pap smears are too personal to
talk about with family and friends. “Huh uh, nobody but my doctor. Because it ain’t nobody’s
business but my doctor, me and my doctor. Whatever goes on, yeah, me, my doctor, and my
partner,” [Age 41, Less than High School]. Actually, the same was true for other types of
screenings as well; the participants knew about those from medical providers, or maybe from
television advertisements or the internet. While talking about it, one participant seemed to realize
how heavily she relied on her doctor, saying, “My doctor, she always, you know, about the
glucose and the diabetes class, she’s always the one that, because she checks for everything, so
she’s always the one that kind of keeps me abreast of the screenings I should have, the vaccines I
should have, so I just, it’s sad to say, but I just completely 100% trust her to kind of keep me
healthy,” [Age 35, High School Graduate].
However, most participants described having a strong support system, maybe not large in
number but close-knit. These were family members, such as parents, siblings, significant others,
or even children, and friends, and they were very encouraging of the women to stay on top of
their health, especially with regard to HIV. “My family. My family and my fiancée, they’re very
supportive. They tell me, um, ‘I’m proud of you’, ‘you’re doing good’, ‘keep taking your

74

medicine’, ‘keep going to the doctor and let me know what’s going on with you,’” [Age 41, Less
than High School].
It would appear then that the issue is not a lack of social support related to Pap test
screening, but rather that it plays a limited role, even while support is provided for HIV and
overall health. One participant expressed this sentiment well when she said:
“So I have a team as far as that’s concerned, as far as just overall general health and
trying to keep myself healthy, lose some weight, try to lower my glucose levels, stuff like
that. But I don’t know, I just don’t, I’m sure if I tell them about the Pap smear, they’ll
probably remind me of that too, I just think some things are a little too personal. Like we
can talk about the weight, but we’re not going to talk about that it’s time to check my
vagina, now I don’t want to talk about that so…” [Age 35, High School Graduate].
Participants were asked specifically if their church offered any support in regards to their
health, and Pap test screening in particular. Not surprisingly, churches did not discuss or provide
information on HPV, cervical cancer, or Pap smears, even if they offered health fairs or had
other forms of health ministries. “Not really, you know, they may have a health fair every now
and then, but they tend to steer away from a lot of stuff, so truth be told, and they did a health
fair just a couple of months ago, I don’t remember seeing nothing about Pap smears or the
importance of Pap smears,” [Age 35, High School Graduate]. Some churches did have prayer
ministries and make hospital and home visits to sick people in need. “They do, they send prayers
to the peoples who’s been in the hospital or been sickly or whatever,” [Age 41, Less than High
School].
Disconnect Between Health and Spirituality. Although results from the participant
questionnaires indicated most of the women, nearly 85%, felt their religious beliefs were very
important to them, many did not see the connection between these beliefs and their health, seeing
them as two separate, even opposing, aspects of their lives. Many of the women discussed
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believing in the healing power of prayer: “I mean, I pray all day, every day, whew, man, it ain’t a
word that don’t come out of my mouth that doesn’t say ‘Lord please, help me and give me
strength’. I believe God is my higher power and He is the reason I am here. It ain’t because of
medicine, it was like some of the medicine, but it’s because of Him I’m here,” [Age 37, Less
than High School]. While acknowledging belief in God’s ability to heal and in the power of
prayer, a few of the women had been able to reconcile these beliefs in conjunction with western
medicine. One participant resolved it this way: “To me, I’m like, ‘Yeah, that’s right, faith
without works is death,’ and I do understand that I can’t sit here and continue to pray to God
about healing me from HIV or diabetes or whatever it is; I can sit here and pray about this
diabetes all day, but what good is it if I’m praying about it and still eating a box of cupcakes?”
[Age 35, High School Graduate].
Although it seems contradictory given they were generally engaged in medical care,
some of the participants expressed a “Let go, let God” sentiment. “No, I just ‘Let go, let God’.
Let God, put everything in the Lord’s hands and He’s going to work it out,” [Age 41, Less than
High School]. This mentality emphasizes the distinction some participants saw between their
health and their religious beliefs, which could be justification to some women for not engaging in
traditional medical care. One woman recognized the dichotomy, saying,
“Well, if I went strictly by my religious beliefs, I would just completely rely on God to
heal and fix everything, and don’t get me wrong, I know He’s able to do all things, but I
also know that He blesses us with physicians and other people to help us keep a healthy
us, so uh, I know people that use this certain scripture to apply to, you know, faith, uh,
you’re healed by His stripes. I don’t doubt that, but I know if I don’t, if I don’t take this
medication or if I don’t get these different screenings, healing by the stripes is very
irrelevant at that point, you know?” [Age 35, High School Graduate].
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Still, a handful of participants did consider their faith to be motivation for staying
healthy, including regular engagement in Pap test screening. “It helps me to stay positive. It’s
helped me to take my medicine. It’s helped me to just get up, to just go and be motivated, it’s
motivation,” [Age 36, Less than High School]. One participant said she owed it to God to keep
up with her health because of all the good He had brought to her life: “The lifestyle that I used to
live, and God done changed me from the inside out and changed my whole lifestyle, you know,
I’m a true believe that only God did it, I didn’t do it, so if he did this for me then why I can’t do
this for myself, keep myself health?” [Age 41, Less than High School].
Contextual Considerations
HIV as a Facilitator. Half of the women said having HIV made them want to take better
care of themselves, actually serving as motivation for them to keep up with annual Pap test
screening. The women recognized the vulnerability associated with being immune-compromised
due to HIV, and wanted to stay healthy. Additionally, as mentioned previously, the women saw
Pap smears as a basic part of women’s health and understood that early detection of a problem is
better for treatment. “Yes, it makes me want one more frequently to keep, to make sure I’m
healthy,” [Age 41, 1999 HIV Diagnosis]. One participant admitted she did not keep up with
cervical cancer screening before HIV: “And to be honest I didn’t really start getting regular Pap
smears until I became HIV-positive,” [Age 35, 2001 HIV Diagnosis].
Organizational Dynamics
Reliance on Healthcare Provider. The women’s healthcare providers largely served as
the women’s cue to action for Pap test screening. Nearly all of the participants had their Pap
smears scheduled for them or incorporated into their routine HIV care appointments. “Normally
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she’ll [the doctor] ask me at my visits since I see her so often, and she’ll be like, ‘Is it time?’ or
take a look in my chart, and normally they’ll tell me when it’s time for my Pap and then do it
there in the office so I don’t have to see a separate doctor or anything to get my Pap,” [Age 35,
Ryan White Participant, 3 Doctor Visits Per Year]. In addition, the doctor’s office would call,
text, or email to remind the women of their upcoming appointments a few days in advance,
allowing them to easily confirm or reschedule if needed. “One thing that I have noticed with the
medical people, that they have started emailing patients now about their appointments or they
will have their nurses make calls to the patients to remind them that they have an appointment,”
[Age 44, Ryan White Participant, 3 Doctor Visits Per Year]. In short, the healthcare providers
essentially served as Cues to Action for the women to engage in regular Pap test screening.
The women described having a good relationship with the doctor who performed their
most recent Pap smear. Most of these providers were female and they were described as nice,
informative, and helpful. They were concerned with the women’s comfort, and explained the
step-by-step process of the exam. “It was very comfortable, I like it that she explained to me
what she was doing, um, you know, she, she kind of talked me through, you know,” [Age 35,
Ryan White Participant, 3 Doctor Visits Per Year]. Several of their women received
comprehensive care through their healthcare provider, so their Pap smears were incorporated into
their regular HIV appointments. There was an established, trusted relationship between patient
and provider. “I mean, I wouldn’t change, I wouldn’t want to change because that’s my doctor
and I’ve been seeing her for awhile, so I’m comfortable with seeing her,” [Age 41, Ryan White
Participant, 3 Doctor Visits Per Year]. In terms of health, the providers were the participants’
main source of social support, especially for sexual and reproductive health. At least one
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participant recognized this issue, vocalizing the sentiment this way: “Yeah, she [the doctor]
reminds me, and I hate that because I know I’m supposed to be on top of it and I rely on her to
remind me, be like, ‘Hey, it’s that time,’ because am I really, really excited about the Pap smear?
No,” [Age 35, Ryan White Participant, 3 Doctor Visits Per Year].
Intersectionality
Public health issues never occur in a vacuum, and this study sought to examine Pap test
screening among HIV-positive women in the Mid-South through psychosocial, cultural,
contextual, and organizational lenses. The major themes identified within each socioecological
layer have been described, but it is also necessary to consider how they interact together. The
participants in this study were engaged in regular Pap test screening, just as they kept up with
their HIV care. In fact, the two were often done in conjunction with each other, and in
partnership with an established, trusted healthcare provider. Not only did the women rely on their
doctors to schedule their appointments, but they also kept these appointments largely in
following doctors’ orders. While they knew of Pap test screening as an important part of
women’s healthcare, they lacked specific knowledge of the relationships between HPV, cervical
cancer, and Pap smears; however, this did not keep them from complying with current
guidelines. Being HIV-positive seemed to have a large influence on this compliance because the
women recognized their increased vulnerability from being immune-compromised and so were
motivated to keep up with preventive healthcare measures. From this perspective, the benefits of
Pap test screening far outweighed its disadvantages.
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CHAPTER 4: DISCUSSION
This study aimed to answer two research questions: 1.) What psychosocial, cultural,
contextual, and organizational factors influence HIV-positive women’s engagement in cervical
cancer screening? and 2.) How do these factors intersect with each other to affect HIV-positive
women’s engagement in cervical cancer screening? Through one-on-one interviews, participants
discussed their thoughts on and experiences with cervical cancer screening, with a demographic
questionnaire and knowledge survey providing background information. Several interesting
themes across multiple socioecological levels emerged from the data, including the factors that
guided women’s engagement with Pap test screening. In addition to identifying such facilitators
and barriers, this research also attempted to examine their interactions.
What psychosocial, cultural, contextual, and organizational factors influence
HIV-positive women’s engagement in cervical cancer screening?
Psychosocial Factors
Psychosocial questions for the one-on-one interviews asked participants about their
personal experiences with Pap test screening and were based on constructs from well-known
public health theories, such as the HBM. The HBM is a good and stable predictor for both
screening and treatment behaviors because it considers both perceptions of disease as well as
beliefs about health behaviors, rather than just one or the other, to be motivators for taking action
(Carpenter, 2010; Tanner-Smith & Brown, 2010). Drawing from the HBM, the women in this
study were asked what advantages and disadvantages, benefits and barriers exist to engaging in
Pap test screening for themselves and women in general. They also discussed how much they
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worry about cervical cancer, how an abnormal Pap smear or cervical cancer diagnosis would
impact their life, and what cues trigger or remind them to get a Pap smear.
Knowledge. Although knowledge alone does not motivate people’s decision-making, it
does lay the foundation for beliefs and perceptions; thus, it is generally considered necessary but
not sufficient for motivating a particular health behavior (DiClemente, 1989; Fisher & Fisher,
1992). In the present study, participants’ knowledge of Pap test screening and its relationship to
HPV and cervical cancer were assessed through both Brietkopf et al’s (2005) Knowledge of Pap
Screening survey and interview discussions. Much of the literature, regardless of the sample
being studied, suggests women have limited knowledge regarding HPV, cervical cancer, and Pap
test screening (Daley et al., 2013; Friedman & Shepeard, 2006; Kobetz et al., 2010; Montgomery
et al., 2010; Mosavel & El-Shaawari, 2007; Nardi et al., 2016; Nolan et al., 2014). This finding is
consistent throughout the research, with little to no disparities found among different age, race,
or socioeconomic groups.
In Brietkopf et al’s (2005) research validating the measure used in this study, the average
score for the entire sample of 338 Texas women was 8.7 out of a possible 20. Breaking the
average scores down by race, White women scored the highest with 10.2, African American
women were next 8.4, and Hispanic women scored the lowest with 7.4. Interestingly, scores did
not differ based on Pap screening history, but lower socioeconomic status was associated with a
lower score. The women in the current study were African American and low income, but had an
overall mean score of 12.3, higher than any average in Brietkopf et al’s study (2005). Comparing
the women in this study with African American women in Brietkopf et al’s study (2005), the
same was true of the Purpose and Symptoms subscores, with means being 2.8 vs 1.7 and 3.7 vs
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2.1, respectively. However, the participants in Brietkopf et al’s (2005) study scored higher on the
Abnormal Pap Smear subscore than did the women in this study, 2.5 vs 2.1. Brietkopf and
colleagues (2005) did not report scores for the Follow-Up subscale. The women in the two
studies were similar, but the participants in the present study were likely more aware of their
health and motivated to gain health-related knowledge given their HIV status.
In their meta-analysis, Wong and colleagues (2018) found that inadequate knowledge of
HPV transmission and cervical cancer prevention were common among women living with HIV.
Although the women in the study presented here also had limited knowledge on the subject, it
did not appear to keep them from engaging in regular Pap test screening. At least one other study
has reported this same phenomenon, and found knowledge to be positively correlated with selfefficacy and benefits, while having a negative relationship with perceived barriers (Lambert et
al., 2015).
Benefits versus Barriers. For the women in this study, the leading benefit of engaging
in Pap test screening was staying on top of their health and knowing what was happening with
their body; conversely, the most commonly mentioned barrier was pain, both physical and
emotional. The issues of physical pain and emotional discomfort associated with Pap test
screening are not unique to HIV-positive women (Duffett-Leger et al., 2008). Beyond simply
identifying perceived benefits and barriers to Pap test screening, the findings in this study also
demonstrated that the pain and discomfort associated with Pap smears does not necessarily keep
women from engaging in this screening behavior. This notion has been previously demonstrated
in a study of HIV-positive women in Texas; in their study, Fletcher, Buchberg, and colleagues
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(2014) found that pain was described as the primary barrier to Pap smears and subsequent
testing, but that nearly 80% of their participants still had a Pap smear in the last year.
Regarding emotional discomfort, one of the most salient descriptions from a participant
in this study was the comparison of the Pap smear to being raped. While this may simply be
hyperbole, it nevertheless raises concern that screening examinations may actually be traumatic
for patients. In a study of the experience of a Pap smear among women with a history of trauma
or abuse, all but one indicated having an emotional response during the exam (Ackerson, 2012).
Specifically, the perception of being “forced” to have the test, undressing, putting feet in stirrups,
and insertion were the most traumatic aspects of the test. However, many attempted to control
their emotions and still receive a Pap smear versus one-quarter who stated they avoided Pap test
screening altogether. Also interesting, almost none of the participants had discussed their
previous trauma with their doctor. The issue of emotional discomfort is particularly concerning
for women living with HIV/AIDS because they may be at greater risk than the average woman of
experiencing intimate partner violence (Phillips et al., 2014). Lichtenstein (2005) found the
women in his study attributed intimate partner violence to their acquisition of HIV.
Participants in this study also discussed the fear of having some type of diagnosis,
whether an abnormal result, HPV, or even cervical cancer, and this on top of already being
diagnosed with HIV. As mentioned previously, this concern is not unique to HIV-positive
women; fear of an undesirable result is common for any test, and especially for those who have
already faced a difficult diagnosis (Aranda-Naranjo et al., 2005; Nolan et al., 2014; Studts,
Tarasenko, & Schoenberg, 2013). While fear of an abnormal Pap test result or another diagnosis
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certainly existed, participants in this study still recognized the importance of early diagnosis for
treatment and best outcomes.
Oftentimes, barriers to Pap test screening are logistical in nature, such as transportation,
cost, accessing care, etc (Andrasik et al., 2008; Daley et al., 2013; Studts et al., 2013). However,
these traditional barriers were generally non-issues for participants in this study. This could be
related to the large proportion of the sample who were enrolled in the Ryan White program,
which provides medical case management, comprehensive care, primary care coverage, and
transportation, among other services. Multiple studies have demonstrated the efficacy of the
services provided by the Ryan White program, which directly translates to improved HIV
outcomes (Diepstra et al., 2016; Hirschhorn et al., 2009; Irvine et al., 2014; Lopez, Shacham, &
Brown, 2018). However, Ryan White participants may still have unmet needs; one study found
that 90% of women, compared to 76% of men, received medical case management through Ryan
White and two-thirds of all participants had access to a directory of services and resources, but
nearly half of the participants still had at least one unmet need, with the top four being dental
care, housing, transportation, and food (Kenagy et al., 2003). Similarly, the 2012 Comprehensive
Needs Assessment for the Memphis TGA found 43% of PLWHA had an unmet need related to
comprehensive medical care, with higher disparities in the rural versus urban counties (Pichon et
al., 2012).
Cultural Influences
Culture is a shared system of values, beliefs, behaviors, social patterns, and other
customs, and has a significant impact, whether consciously or subconsciously, on an individual’s
health (Steele-Moses et al., 2009). An individual’s social network describes their system of
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relationships and social support, both their characteristics and functions (Heaney & Israel, 2008).
The one-on-one interviews in this study asked participants to not only identify who they talk
with about Pap smears, cervical cancer, HIV, and their health in general, but also what is said
between them.
Social Support. There are many types of social support, from received and perceived
(Dukel-Schetter & Skokan, 1990) to emotional, informational, and tangible (Cohen et al., 1985).
This study largely focused on the latter, asking the women who talks to them and gives them
information about health-related matters. Social support also comes from either formal sources,
such as healthcare providers, or informal sources, including family and friends (Heaney & Israel,
2008). Most of the women in this study had a support system of informal sources in place to help
them and encourage them with HIV care and their overall health. Social support on this level,
however, had limited influence on the participants’ engagement with Pap test screening because
the subject was deemed too personal and intimate. Thus, the women relied more on formal
sources of social support, specifically their healthcare providers, to discuss such matters.
Other studies have demonstrated similar findings, with social support having a
borderline, minor, or mediating role on sexual health behaviors (Clum, Chung, Ellen, & The
Adolscent Medicine Trials Network for HIV/AIDS Interventions, 2009; Documet et al., 2015).
Nearly two-thirds of the participants in the study presented here indicated they were single, but
some did mention discussing their gynecological health with their sexual partners, although the
exact nature of these relationships was not necessarily known. The association between cervical
cancer screening and marital status has been examined, with cervical cancer screening being
significantly higher among married women (83.9%) compared to their never married (78.7%)
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and divorced/ widowed/ separated (75.1%) counterparts (Hanske et al., 2016). Alternatively,
other studies have shown that significant others may discourage women from having Pap smears
because of jealousy, the intimate nature of the test, and abusive control (Leite et al., 2016;
Phillips et al., 2014; Williams et al., 2015). More research is needed to determine the role
significant others and sexual partners might have on influencing an HIV-positive woman’s
engagement with Pap test screening.
Religiosity. Religiosity is another important aspect of culture, especially for African
Americans (Holt et al., 2017). As a construct, religiosity is multidimensional and encompasses
both religion and spirituality, from the quantitative aspect of service attendance to more
qualitative beliefs about the power of prayer (Szaflarski, 2013). In this study, the women were
asked what religion, if any, they identify with and how important their religion is to them on the
demographic questionnaire. They were also asked to discuss how their spiritual beliefs influence
their health, including HIV status and Pap test screening, in the one-on-one interviews.
The women in this study had mixed feelings about if or how their religious and spiritual
beliefs influenced their health. The literature on this subject is similarly mixed (Wigfall et al.,
2012). For instance, in their prospective, long-term study of the association between religion and
HAART adherence among HIV-positive patients at a San Diego clinic, Vyas, Limneos, Qin, and
Mathews (2014) found those whose beliefs gave their lives meaning, connected them to a higher
being and humanity, and influenced their recovery were more likely to achieve 90% adherence.
In contrast, those who believed God created all things in the universe, that God will not His turn
back on them, and who had higher attendance of religious services, were less likely to have 90%
adherence. Qualitative studies have demonstrated that people living with HIV/AIDS for several
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years see it as a spiritual journey, and that spirituality, rather than organized religion, can help
with coping, provide social support, and decrease stress, pain, and depression (Dalmida et al.,
2012; Emlet, Harris, Pierpaoli, & Fulotte, 2017; Slomka, Lim, Gripshover, & Daly, 2013). In
their meta-analysis of religious beliefs and HIV, Szaflarski (2013) found spirituality to be multidimensional, having a direct influence on health and quality of life as well as mediating health
behaviors, optimism, and social support; additionally, religious beliefs helped people living with
HIV cope with stressors, particularly stigma and prejudice, in part through the power of prayer
and meditation.
Contextual Considerations
To fully understand the uptake of Pap test screening among African American, HIVpositive women in the Mid-South, the perspective from which the participants view the behavior
must be considered. This context encompasses not only the physical, environmental qualities of a
community, but also the social and cultural aspects (Berkman, 2009; Krieger, 2001). Stokols
(1996) lists five potential roles of the environment in relation to health: Transmitter of Diseases,
Stressor, Source of Safety or Danger, Enabler of Healthy Behaviors, or Provider of Health
Resources. Specifically, this study sought to examine cervical cancer screening in the context of
living with HIV.
Fatalism. Much of the literature indicates fatalistic beliefs related to chronic diseases,
including HIV/AIDS, may disengage people from screenings and healthcare because they
believe some negative outcome associated with the condition is inevitable (Eastwood et al.,
2015; Hotz, 2015; Jones, Frohwirth, & Blades, 2016; Marlow, Ferrer, Chorley, Haddrell, &
Waller, 2018; Steward, Koester, Myers, & Morin, 2006; Vanderpool, Dressler, Stradtman, &
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Crosby, 2015; Vu, Azmat, Radejko, & Padela, 2016;). However, the opposite was true for
women in this study, where being HIV-positive actually served as a facilitator for engaging in
Pap test screening, and this notion was supported by at least one other study (Bynum et al.,
2016). Drew and Schoenberg (2011) have deconstructed Fatalism, describing the term as a catchall that actually masks complex life constraints and fear of change. Through case studies of
cervical cancer screening among Appalachian women, they demonstrate fatalistic health beliefs
and issues of choice and control exist on a continuum of active pursuit versus active restraint,
from seeking out information and biomedical services to ambivalence or submission to
healthcare authorities. Research on the role of fatalism in HIV-positive women’s engaging in
other health screening is limited and warrants more attention. Self-esteem may be used as a
measure of confidence, especially in terms of overcoming obstacles. One study of young HIVpositive women between the ages of 17 and 24 years old found a wide range of self-esteem;
some had high self-esteem and said HIV had no impact on their life goals and dreams, while
others had become less hopeful and felt less good about themselves since their diagnosis (Hosek
et al., 2012).
Organizational Dynamics
The healthcare system itself has an influence on an individual’s health behaviors, with
past experiences positively or negatively affecting future engagement. These organizational-level
factors may be related to the clinic and setting itself, such as location, appointment availability,
and waiting time, or to the healthcare providers and staff who interact with patients. Patient–
provider relationships have the potential to reduce health system failures among patients with
low health literacy (Wigfall et al., 2017). Thus, the interview discussion in this study asked
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participants not only about their experience with Pap smear exams at their clinic, including
scheduling, setting and mood, hospitality of staff, obtaining results, etc., but also their
relationships with their healthcare provider.
Healthcare Providers. In this study, healthcare providers were essential to facilitating
Pap test screening, from tracking when the participants were due for a Pap smear to
automatically scheduling appointments and referrals. This likely explains the high rate of Pap
screening adherence among the participants; all of the women indicated they had received a Pap
smear within a year of their interview date, and all of those who had had an abnormal Pap result
said they received follow-up care within a year. This phenomenon conflicts with other literature
on distrust of healthcare providers and the medical system among people of color (Driscoll,
2016; Mattocks et al., 2017; Nolan et al., 2014). However, there are numerous examples within
the literature of how the relationship a patient has with his/her healthcare provider can either
positively or negatively influence engagement in HIV care (Hawk et al., 2017; Landovitz,
Desmond, Gildner, & Leibowitz, 2016; Slomka et al., 2013;), as well as Pap test screening for
women (Ackerson, 2012; Nonzee et al., 2015; Peralta, Holaday, & Hadoto, 2017).
While it is certainly beneficial for the women in this study to have positive relationships
with their healthcare providers, total reliance on their doctors to keep them engaged in Pap test
screening could be problematic. For instance, participants may not schedule or keep Pap smear
appointments if their providers did not do it for them (Hawk et al., 2017; Wigfall et al., 2017). In
their study of more than 1,300 HIV-positive patients at an urban, academic medical center,
Flickinger and colleagues (2013) found participants who had positive relationships and
communication with their providers were more likely to keep their appointments and achieve
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retention in care. Thus, the high rate of compliance with regular Pap test screening in this study
may be fragile, potentially declining if the patient – provider relationship were to break down.
Intersection of Cervical Cancer Screening Influences
Intersectionality as a framework seeks to understand the impact of multiple marginalized
identities on individuals. The concept was first discussed in terms of African American women,
who experience both racial discrimination and sexual biases (Perry, Harp, & Oser, 2013), but
also experience them simultaneously, with the combined impact having more weight than the
two separately (Lewis, Williams, Peppers, & Gadson, 2017). Researchers are starting to utilize
the intersectionality framework to examine health outcomes among African American women.
For instance, one study assessed how simultaneously experiencing sexism and racism affected
African American women’s health (Lewis et al., 2017). They found participants whose selfconcept was less grounded in their gender and racial identity were more likely to disengage from
society as a coping strategy, which negatively affected both their mental and physical health.
Williamson, Mahmood, Kuhn, and Thames (2017) sought to examine the intersection of race,
discrimination, depression, and HIV status among women, and identified a 3-way interaction
does exist between social adversity, HIV status, and race. There was a direct relationship
between discrimination and depression for HIV-positive African American women, but not for
HIV-negative African American women nor White women regardless of HIV status.
One study examined how cultural and structural factors influence Pap test screening
among Latina women in Los Angeles, and identified several predictors, including structural
barriers, fatalism, attending religious services, perceived susceptibility, perceived costs, and cues
to action from a healthcare provider (Chen, Moran, Frank, Ball-Rokeach, & Murphy, 2018).
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Similarly, the women in the present study were motivated to engage in Pap test screening by the
belief that the benefits of Pap smears outweigh the costs, perceived susceptibility due to their
HIV-positive status, and cues to action from healthcare providers. That the subjects of this study
are women, that they are African–American, and that they are situated in Memphis are all crucial
to understanding the dynamics of their faith, their health-seeking behaviors, and the particular
ways in which they narrate the meanings of their bodies (Hotz, 2015).
Strengths and Limitations
A major strength of this study, and qualitative methods in general, is that the results are
grounded in the data itself. Findings from this study emerged from the participants’ descriptions
of their experiences and have been reported using the participants’ own words. Additionally, the
interview guide was designed to discuss facilitators and barriers to Pap test screening across
multiple socioecological levels, from individual to cultural to organizational. The qualitative
nature of this study and reflexivity of the interview guide also allowed for discussions of
intersectionality, forming a more complete representation of Pap test screening among this
population.
One distinct quality of this study is its concentration on HIV-positive women. Much of
the international HIV research is focused on meeting the needs of women, sex workers, and
preventing mother-child transmission, but this is not always the case in the United States, where
the focus is largely on men who have sex with men (MSM) and the transgender community. This
study examines a common women’s health behavior from the unique perspective of women
living with HIV, a complex, often-stigmatized condition. However, the inclusion criteria for this
study limited the pool of potential participants, which led to the relatively small sample size of
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19. Still, this size is not unusual for qualitative research, and the point of saturation, when no
new themes were emerging from the data, was met (Creswell, 2007).
All of the participants in study were engaged in HIV care and in compliance with Pap test
screening guidelines, which provided for thick description of this subpopulation’s experiences.
However, other perspectives may not be represented, including HIV-positive women who are not
engaged in regular care and those who do not receive basic women’s healthcare. In an effort to
recruit a wider sample of the population, social services agencies as well as healthcare clinics
posted study flyers and allowed in-person representatives to meet with potential participants.
Advertisements were also sent electronically through related email distribution lists.
Regarding data collection and analysis, both have limitations involving the number of
researchers. Multiple researchers conducted interviews with participants, meaning that, while the
same overall collection methods were utilized, there may have been variability in styles. All
interviewers completed CITI training, reviewed the study protocol and interview guide, and
listened to interview recordings. Grounded theory methods of analysis were employed, including
open, axial, and selective coding, but reliability may have been increased if multiple researchers
independently coded the data then came together to develop a consensus. Nevertheless, the
findings of this study should be considered reliable because the participants’ own words are used
to explain the emerging themes.
Future Research
To the author’s knowledge, this is the first study of its kind to be conducted with this
population and in the Mid-South region, making its findings important not only for local public
health practitioners and interventions, but also other researchers in the field. While this research
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provides a unique insight into this issue, more research is needed. Specifically, it would be
beneficial to reach HIV-positive women who were not as actively engaged in care as the
participants in this sample. Additionally, it may of interest to further examine differences
between women who have had an abnormal Pap smear result and those who have not. One
barrier mentioned in this study was emotional pain, and other literature indicates sexual abuse
and intimate partner violence may influence the uptake of Pap test screening. More research on
this connection between emotional trauma and cervical cancer screening, or even other
screenings, is warranted. The religiosity factor deserves more exploration, specifically
differences in religion and spirituality. Similar studies could be done on anal Pap test screening
and HIV-positive transwoman. As HIV is now considered a chronic disease, it may be necessary
to assess other preventive health and screening behaviors, such as mammography, colonoscopies,
diabetes, and heart disease.
The findings presented here provide insight into what motivates some HIV-positive
women to engage in annual Pap test screening. The qualitative methods employed here allow for
more in-depth information beyond simply a list of facilitators and barriers. This study could
provide public health practitioners with a deeper understanding of women’s engagement in
cervical cancer screening compliance. Healthcare providers may apply these results to improve
their relationships and communication with patients, especially considerations of physical and
emotional pain. They may also be more aware of patients’ possible lack of knowledge or sources
of information, and help to educate women on HPV and cervical cancer.
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Conclusions
The purpose of this study was to explore the motivations, facilitators, and barriers to
annual Pap test screening among HIV-positive women in the Mid-South. To achieve this end,
psychosocial, cultural, contextual, and organizational factors were considered, as well as the
intersections among them. Participants in this study were generally in compliance with Pap test
screening guidelines, even though their knowledge of it was limited. Interestingly, their HIV
status largely helped facilitate this compliance because participants were aware of their increased
vulnerability from being immune-compromised. They also had established relationships with
their healthcare providers, who were able to schedule, or even perform, Pap smears for them.
Although most participants had strong support systems, Pap test screening was not something
they discussed; however, their significant others, family, and friends encouraged them about
their health overall. Although more research is needed, the results of this study could provide
insight for public health interventions to increase knowledge about HPV and cervical cancer,
awareness of the purpose and availability of Pap smears, and uptake of Pap test screening.

94

Works Cited
Abercrombie, P.D. (2003). Factors Affecting Abnormal Pap Smear Follow-Up among HIVInfected Women. Journal of the Association of Nurses in AIDS Care, 14(3): 41 – 54.
Ackerson, K. (2010). Personal Influences that Affect Motivation in Pap Smear Testing among
African American Women. Journal of Obstetric, Gynecology and Neonatal Nursing, 39(2): 136
– 146.
Ackerson, K. (2011). Interactive Model of Client Health Behavior and Cervical Cancer
Screening of African-American Women. Public Health Nursing, 28(3): 271 – 280.
Ackerson, K. (2012). A History of Interpersonal Trauma and the Gynecological Exam.
Qualitative Health Research, 22(5): 679 – 688.
Ahdieh, L., Klein, R.S., Burk, R., Cu-Uvin, S., Schuman, P., Duerr, A., Safaeian, M.,
Astemborski, J., Daniel, R., and Shah, K. (2001). Prevalence, Incidence, and Type-Specific
Persistence of Human Papillomavirus in Human Immunodeficiency Virus (HIV)-Positive and
HIV-Negative Women. The Journal of Infectious Diseases, 184(6): 682 – 690.
Aizer, A.A., Chen, M.H., McCarthy, E.P., Mendu, M.L., Koo, S., Wilhite, T.J., Graham, P.L.,
Choueiri, T.K., Hoffman, K.E., Martin, N.E., Hu, J.C., and Nguyen, P.L. (2013). Marital Status
and Survival in Patients with Cancer. Journal of Clinical Oncology, 31(31): 3869 – 3876.
Anderson, J.R., Paramsothy, P., Heilig, C., Jamieson, D.J., Shah, K., and Duerr, A. (2006).
Accuracy of Papanicolaou Test among HIV-Infected Women. Clinical Infectious Diseases,
42(4): 562 – 568.
Andrasik, M.P., Rose, R., Pereira, D., and Antoni, M. (2008). Barriers to Cervical Cancer
Screening among Low-Income HIV-Positive African American Women. Journal of Health Care
for the Poor and Underserved, 19(3): 912 – 925.
Aranda-Naranjo, B., Barini-Garcia, M., and Pines, E.W. (2005). “I Can’t Deal with One More
Piece of Bad News”: The Voices of Women Living with HIV Infection in an Inner City
Gynecology Clinic. The Journal of Multicultural Nursing & Health, 11(1): 84 – 92.
Badial, R.M., Dias, M.C., Stuqui, B., Melli, P.P., Quintana, S.M., Bonfim, C.M., Cordeiro, J.A.,
Rabachini, T., Calmon, M., Provazzi, P.J.S., and Rahal, P. (2018). Medicine, 97(14): 1 – 6.
Baranoski, A.S., Horburgh, C.R., Cupples, L.A., Aschengrau, A., and Stier, E.A. (2011). Risk
Factors for Non-Adherence with Pap Testing in HIV-Infected Women. Journal of Women’s
Health, 20(11): 1635 – 1643.

95

Baranoski, A.S. and Stier, E.A. (2012). Factors Associated with Time to Colposcopy after
Abnormal Pap Testing in HIV-Infected Women. Journal of Women’s Health, 21(4): 418 – 424.
Baumgartner, L.M. and David, K.N. (2009). Accepting Being Poz: The Incorporation of the HIV
Identity into the Self. Qualitative Health Research, 19(12): 1730 – 1743.
Benard, V.B., Thomas, C.C., King, J., Massetii, G.M., Doria-Rose, V.P., and Saraiya, M. (2014).
Vital Signs: Cervical Cancer Incidence, Mortality, and Screening – United States, 2007 – 2012.
Morbidity and Mortality Weekly Report, 63(44): 1004 – 1009.
Berkman, L.F. (2009). Social Epidemiology: Social Determinants of Health in the United States:
Are We Losing Ground? Annual Review of Public Health, 30: 27 – 41.
Breitkopf, C.R., Pearson, H.C., and Breitkopf, D.M. (2005). Poor Knowledge Regarding the
PapTest among Low-Income Women Undergoing Routine Screening. Perspectives on Sexual
and Reproductive Health, 37(2): 78 – 84.
Bynum, S.A., Wigfall, L.T., Brandt, H.M., Julious, C.H., Glover, S.H., and Hebert, J.R. (2016).
Social and Structural Determinants of Cervical Health among Women Engaged in HIV Care.
AIDS Behavior, 20: 2101 – 2109.
Callahan, T.L. and Caughey, A.B. (2007). Cervical Neoplasia and Cervical Cancer. In
Blueprints: Obstetrics and Gynecology (4th ed., pp. 296-307). Baltimore, MD: Lippincott
Williams & Wilkins.
Carpenter, C.J. (2010). A Meta-Analysis of the Effectiveness of Health Belief Model Variables
in Predicting Behavior. Health Communication, 25: 661 – 669.
Cates, J.R., Brewer, N.T., Fazekas, K.I., Mitchell, C.E., and Smith, J.S. (2009). Racial
Differences in HPV Knowledge, HPV Vaccine Acceptability, and Related Beliefs among Rural,
Southern Women. Journal of Rural Health, 25(1): 93 – 97.
Chen, N.N.T., Moran, M.B., Frank, L.B., Ball-Rokeach, S.J., and Murphy, S.T. (2018).
Understanding Cervical Cancer Screening among Latinas through the Lens of Structure, Culture,
Psychology, and Communication. Journal of Health Communication, 23(7): 661 – 669.
Chin-Hong, P.V. and Palefsky, J.M. (2005). Human Papillomavirus Anogenital Disease in HIVInfected Individuals. Dermatologic Therapy, 28: 67 – 78.
Clum, G., Chung, S.E., Ellen, J.M., and The Adolescent Medicine Trials Network for HIV/AIDS
Interventions. Mediators of HIV-Related Stigma and Risk Behavior in HIV Infected Young
Women. AIDS Care, 21(11): 1455 – 1462.

96

Cohen, S., Mermelstein, R., Kamarck, T., and Hoberman, H.M. (1985). Measuring the
Functional Components of Social Support. In Sarason, I.G. (Ed.), Social Support: Theory,
Research, and Applications (pp. 73 – 94). Netherlands: Springer.
Corbin, J. and Strauss, A. (1990). Grounded Theory Research: Procedures, Canons, and
Evaluative Criteria. Qualitative Sociology, 13(1): 3 – 21.
Creswell, J.W. (2007). Qualitative Inquiry and Research Design: Choosing among Five
Approaches (2nd ed., pp. 147-176). Thousand Oaks, CA: Sage Publications, Inc.
Curry, C.L., Sage, Y.H., Vragovic, O., and Stier, E.A. (2012). Minimally Abnormal Pap Testing
and Cervical Histology in HIV-Infected Women. Journal of Women’s Health, 21(1): 87 – 91.
Daley, E., Perrin, K., Vamos, C., Hernandez, N., Anstey, E., Baker, E., Kolar, S., and Ebbert, J.
(2013). Confusion about Pap Smears: Lack of Knowledge among High-Risk Women. Journal of
Women’s Health, 22(1): 67 – 74.
Dalmida, S.G., Holstad, M.M., Dilorio, C., and Laderman, G. (2012). The Meaning and Use of
Spirituality among African American Women Living with HIV/AIDS. Western Journal of
Nursing Research, 34(6): 736 – 765.
Denny-Smith, T., Bairan, A., and Page, M.C. (2005). A Survey of Female Nursing Students’
Knowledge, Health Beliefs, Perceptions of Risk, and Risk Behaviors Regarding Human
Papillomavirus and Cervical Cancer. Journal of the American Academy of Nurse Practitioners,
18: 62 – 69.
DiClemente, R.J. (1989). Prevention of Human Immunodeficiency Virus Infection among
Adolescents: The Interplay of Health Education and Public Policy in the Development and
Implementation of School-Based AIDS Education Programs. AIDS Education and Prevention,
1(1): 70 – 78.
Diepstra, K.L., Rhodes, A.G., Bono, R.S., Patel, S., Yerkes, L.E., and Kimmel, A.D. (2017).
Comprehensive Ryan White Assistance and Human Immunodeficiency Virus Clinical
Outcomes: Retention in Care and Viral Suppression in a Medicaid Nonexpansion State. Clinical
Infectious Diseases, 65(4): 619 – 625.
Digney, S.A., Morrell, K.R., Montgomery, M.A., and Pichon, L.C. (2013). Covariates of
Papanicolaou Test Screening among HIV-Positive Women Receiving Outpatient Medical Care
from the Memphis Transitional Grant Area Ryan White Part A Program. Presented at the
Society of Behavioral Medicine Conference held April 23rd to 26th, 2014, Philadelphia, PA.
Documet, P., Bear, T.M., Flatt, J.D., Macia, L., Trauth, J., and Ricci, E.M. (2015). The
Association of Social Support and Education with Breast and Cervical Cancer Screening. Health
Education and Behavior, 42(1): 55 – 64.
97

Draucker, C.B., Martsolf, D.S., Ross, R., and Rusk, T.B. (2007). Theoretical Sampling and
Category Development in Grounded Theory. Qualitative Health Research, 17(8): 1137 – 1148.
Drew, E.M. and Schoenberg, N.E. (2011). Deconstructing Fatalism: Ethnographic Perspectives
on Women’s Decision Making about Cancer Prevention and Treatment. Medical Anthropology
Quarterly, 25(2): 164 – 182.
Driscoll, S.D. (2016). Barriers and Facilitators to Cervical Cancer Screening in High Incidence
Populations: A Synthesis of Qualitative Evidence. Women and Health, 56(4): 448 – 467.
Duffett-Leger, L.A., Ledourneau, N.L., and Croll, J.C. (2008). Cervical Cancer Screening
Practices among University Women. Journal of Obstetrics, Gynecology and Neonatal Nursing,
37: 572 – 581.
Dunkel-Schetter, C. and Skokan, L.A. (1990). Determinants of Social Support Provision in
Personal Relationships. Journal of Social and Personal Relationships, 7(4): 437 – 450.
Eastwood, E.A., Fletcher, J., Quinlivan, E.B., Verdecias, N., Birnbaum, J.M., and Blank, A.E.,
(2015). Baseline Social Characteristics and Barriers to Care from a Special Projects of National
Significance Women of Color with HIV Study: A Comparison of Urban and Rural Women and
Barriers to HIV Care. AIDS Patient Care and STDs, 29(S1): S4 – S10.
Emlet, C.A., Harris, L., Pierpaoli, C.M., and Furlotte, C. (2018). “The Journey I Have Been
Through”: The Role of Religion and Spirituality in Aging Well Among HIV-Positive Older
Adults. Research on Aging, 40(3): 257 – 280.
Erwin, D.O., Johnson, V.A., Trevino, M., Duke, K., Feliciano, L., and Jandorf, L. (2007). A
Comparison of African American and Latina Social Networks as Indicators for Culturally
Tailoring a Breast and Cervical Cancer Education Intervention. Cancer, 109(2 Suppl): 368 –
377.
Fisher, J.D. and Fisher, W.A. (1992). Changing AIDS Risk Behavior. Psychological Bulletin,
111(3): 455 – 474.
Fletcher, F.E., Buchberg, M., Schover, L.R., Basen-Engquist, K., Kempf, M.C., Arduino, R.C.,
& Vidrine, D.J. (2014). Perceptions of Barriers and Facilitators to Cervical Cancer Screening
among Low-Income, HIV-Infected Women from an Integrated HIV Clinic. AIDS Care, 26(10):
1229 – 1235.
Fletcher, F.E., Vidrine, D.J., Tami-Maury, I., Danysh, H.E., King, R.M., Buchberg, M., Arduino,
R.C., and Gritz, E.R. (2014). Cervical Cancer Screening Adherence among HIV-Positive Female
Smokers in a Comprehensive HIV Clinic. AIDS Behaviors, 18(3): 544 – 554.

98

Flickinger, T.E., Saha, S., Moore, R.D., and Beach, M.C. (2013). Higher Quality
Communication and Relationships are Associated with Improved Patient Engagement in HIV
Care. Journal of Acquired Immune Deficiency Syndrome, 63(3): 362 – 366.
Friedman, A.L. and Shepeard, H. (2007). Exploring the Knowledge, Attitudes, Beliefs, and
Communication Preferences of the General Public Regarding HPV: Findings from CDC Focus
Group Research and Implications for Practice. Health Education and Behavior, 34(3): 471 – 485.
Gamarra, C.J., Paz, E.P., and Griep, R.H. (2009). Social Support and Cervical and Breast Cancer
Screening in Argentinean Women from a Rural Population. Public Health Nursing, 26(3): 269 –
276.
Guilfoyle, S., Franco, R., and Gorin, S.S. (2007). Exploring Older Women’s Approaches to
Cervical Cancer Screening. Health Care for Women International, 28: 930 – 950.
Hanske, J., Meyer, C.P., Sammon, J.D., Choueiri, T.K., Menon, M., Lipsitz, S.R., Noldus, J.,
Nguyen, P.L., Sun, M., and Trinh, Q.D. (2016). The Influence of Marital Status on the Use of
Breast, Cervical, and Colorectal Cancer Screening. Preventive Medicine, 89: 140 – 145.
Hawk, M., Coulter, R.W.S., Egan, J.E., Friedman, M.R., Meanley, S., Fisk, S., Watson, C., and
Kinsky, S. (2017). Exploring the Healthcare Environment and Associations with Clinical
Outcomes of People Living with HIV/AIDS. AIDS Patient Care and STDs, 31(12): 495 – 503.
Head, K.J. and Cohen, E.L. (2012). Young Women’s Perspectives on Cervical Cancer
Prevention in Appalachian Kentucky. Qualitative Health Research, 22(4): 476 – 487.
Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB). (2008). HAB
HIV Core Clinical Performance Measures: Adult/ Adolescent Clients Group 2. Online Available:
http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/pdf/p07-cg/habgrp2pms082.pdf
Health Resources and Services Administration, HIV/AIDS Bureau. (2010). Going the Distance:
The Ryan White HIV/AIDS Program, 20 Years of Leadership, a Legacy of Care. Rockville, MD:
Health Resources and Services Administration.
Heaney, C.A. and Israel, B.A. (2008). Social Networks and Social Support. In Glanz, K., Rimer,
B.K. and Viswanath, K. (Eds.), Health Behavior and Health Education: Theory, Research and
Practice (pp. 189-210). San Francisco, CA: Jossey-Bass.
Hirschhorn, L.R., Landers, S., McInnes, D.K., Malitz, F., Ding, L., Joyce, R., and Cleary, P.D.
(2009). Reported Care Quality in Federal Ryan White HIV/AIDS Program Supported Networks
of HIV/AIDS Care. AIDS Care, 21(6): 799 – 807.

99

Holt, C.L., Roth, D.L., Huang, J., Park, C., and Clark, E.M. (2017). Longitudinal Effects of
Religious Involvement on Religious Coping and Health Behaviors in a National Sample of
African Americans. Social Science Medicine, 187: 11 – 19.
Hosek, S., Brothers, J., Lemos, D., and the Adolescent Medicine Trials Network for HIV/AIDS
Interventions. (2012). What HIV-Positive Young Women Want from Behavioral Interventions:
A Qualitative Approach. AIDS Patient Care and STDs, 26(5): 291 – 297.
Hotz, K.G. (2015). “Big Momma Had Sugar, Imma Have It Too” Medical Fatalism and the
Language of Faith among African-American Women in Memphis. Journal of Religion and
Health, 54: 2212 – 2224.
Irvine, M.K., Chamberlin, S.A., Robbins, R.S., Myers, J.E., Braunstein, S.L., Mitts, B.J.,
Harriman, G.A., and Nash, D. (2015). Improvements in HIV Care Engagement and Viral Load
Suppression Following Enrollment in a Comprehensive HIV Care Coordination Program.
HIV/AIDS, 60(2): 298 – 310.
Jones, R.K., Frohwirth, L.F., and Blades, N.M. (2016). “If I Know I am on the Pill and I Get
Pregnant, It’s an Act of God”: Women’s Views on Fatalism, Agency, and Pregnancy.
Contraception, 93(6): 551 – 555.
Kang, S.H., Bloom, J.R., and Romano, P.S. (1994). Cancer Screening among African-American
Women: Their Use of Tests and Social Support. Annual Review of Public Health, 84: 101 – 103.
Keller, M.J., Burk, R.D., Xie, X., Anastos, K., Massad, L.S., Minkoff, H., Xue, X., D’Souza, G.,
Watts, D.H., Levine, A.M., Castle, P.E., Colie, C., Palefsky, J.M., and Strickler, H.D. (2012).
Risk of Cervical Pre-Cancer and Cancer among HIV-Infected Women with Normal Cervical
Cytology and No Evidence of Oncogenic HPV Infection. Journal of the American Medical
Association, 308(4): 362 – 369.
Keller, M.J., Burk, R.D., Massad, L.S., Eltoum, I.E., Hessol, N.A., Castle, P.E., Anastos, K., Xie,
X., Minkoff, H., Xue, X., D’Souza, G., Flowers, L., Levine, A.M., Colie, C., Rahangdale, L.,
Fischl, M.A., Palefsky, J.M., and Strickler, H.D. (2015). Cervical Precancer Risk of HIVInfected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap
Test. HIV/AIDS, 61(10): 1573 – 1581.
Kenagy, G.P., Linsk, N.L., Bruce, D., Warnecke, R., Gordon, A., Wagaw, F., and Densham, A.
(2003). Service Utilization, Service Barriers, and Gender among HIV-Positive Consumers in
Primary Care. AIDS Patient Care and STDs, 17(5): 235 – 244.
Kobetz, E., Kornfeld, J., Vanderpool, R.C., Rutten, L.J.F., Parekh, N., O’Bryan, G., and Menard,
J. (2010). Knowledge of HPV among United States Hispanic Women: Opportunities and
Challenges for Cancer Prevention. Journal of Health Communication, 15: 22 – 29.

100

Krefting, L. (1991). Rigor in Qualitative Research: The Assessment of Trustworthiness. The
American Journal of Occupational Therapy, 45(3): 214 – 222.
Krieger, N. (2001). Theories for Social Epidemiology in the 21st Century: An Ecosocial
Perspective. International Journal of Epidemiology, 30: 668 – 677.
Lambert, C.C., Chandler, R., McMillan, S., Kromrey, J., Johnson-Mallard, V., and Kurtyka, D.
(2015). Pap Test Adherence, Cervical Cancer Perceptions, and HPV Knowledge among HIVInfected Women in a Community Health Setting. Journal of the Association of Nurses in AIDS
Care, 26(3): 271 – 280.
Landovitz, R.J., Desmond, K.A., Gildner, J.L., and Leibowitz, A.A. (2016). Quality of Care for
HIV/AIDS and for Primary Prevention by HIV Specialists and Nonspecialists. AIDS Patient
Care and STDs, 30(9): 395 – 408.
Leite, F.M.C., Amorim, M.H.C., Primo, C.C., and Gigante, D.P. (2016). Violence Against
Women and Cervical Cancer Screening: A Systematic Review. Journal of Clinical Nursing, 26:
2126 – 2136.
Lekas, H.M., Siegel, K., and Schrimshaw, E.W. (2006). Continuities and Discontinuities in the
Experiences of Felt and Enacted Stigma among Women with HIV/AIDS. Qualitative Health
Research, 16(9): 1165 – 1190.
Lewis, J.A., Williams, M.G., Peppers, E.J., and Gadson, C.A. (2017). Applying Intersectionality
to Explore the Relations Between Gendered Racism and Health among Black Women. Journal
of Counseling Psychology, 64(5): 475 – 486.
Lichtenstein, B. (2005). Domestic Violence, Sexual Ownership, and HIV Risk in Women in the
American Deep South. Social Science and Medicine, 60: 701 – 714.
Liu, G., Sharma, M., Tan, N., and Barnabas, R.V. (2018). HIV-Positive Women Have Higher
Risk of Human Papilloma Virus Infection, Precancerous Lesions, and Cervical Cancer. AIDS,
32(6): 795 – 808.
Lodi, C.T., Michelin, M.A., Lima, M.I., Teixeira, N.C., Adad, S.J., Murta, E.F., and Melo, V.H.
(2011). Factors Associated with Recurrence of Cervical Intraepithelial Neoplasia after
Conization in HIV-Infected and Non-Infected Women. Archives of Gynecology and Obstetrics,
284: 191 – 197.
Logan, J.L., Khambaty, M.Q., D’Souza, K.M., and Menezes, L.J. (2010). Cervical Cancer
Screening among HIV-Infected Women in a Health Department Setting. AIDS Patient Care and
STDs, 24(8): 471 – 475.

101

Lopez, J.D., Shacham, E., and Brown, T. (2018). The Impact of the Ryan White HIV/AIDS
Medical Case Management Program on HIV Clinical Outcomes: A Longitudinal Study. AIDS
and Behavior, 22: 3091 – 3099.
Marlow, L.A.V., Ferrer, R.A., Chorley, A.J., Haddrell, J.B., and Waller, J. (2018). Variation in
Health Beliefs Across Different Types of Cervical Screening Non-Participants. Preventive
Medicine, 111: 204 – 209.
Massad, L.S., Fazzari, M.J., Anastos, K., Klein, R.S., Minkoff, H., Jamieson, D.J., Duerr, A.,
Celentano, D., Gange, S., Cu-Uvin, S., Young, M., Watts, H., Levine, A.M., Schuman, P.,
Harris, T.G., and Strickler, H.D. (2007). Outcomes after Treatment of Cervical Intraepithelial
Neoplasia among Women with HIV. Journal of Lower Genital Tract Disease, 11(2): 90 – 97.
Massad, L.S., Pierce, C.B., Minkoff, H., Watts, D.H., Darragh, T.M., Sanchez-Keeland, L.,
Wright, R.L., Colie, C., and D’Souza, G. (2014). Long-Term Cumulative Incidence of Cervical
Intraepithelial Neoplasia Grade 3 or Worse after Abnormal Cytology: Impact of HIV Infection.
International Journal of Cancer, 134(8): 1854 – 1861.
Mattocks, K.M., Gilbert, C., Fiellin, D., Fiellin, L.E., Jamison, A., Brown, A., and Justice, A.C.
(2017). Mistrust and Endorsement of Human Immunodeficiency Virus Conspiracy Theories
among Human Immunodeficiency Virus- Infected African American Veterans. Military
Medicine, 182: e2073 – e2079.
McLeroy, K.R., Bibeau, D., Steckler, A., and Glanz, K. (1988). An Ecological Perspective on
Health Promotion Programs. Health Education Quarterly, 15(4): 351 – 377.
Miles, M.S., Isler, M.R., Banks, B.B., Sengupta, S., and Corbie-Smith, G. (2011). Silent
Endurance and Profound Loneliness: Socioemotional Suffering in African Americans Living
with HIV in the Rural South. Qualitative Health Research, 21(4): 489 – 501.
Montgomery, K., Bloch, J.R., Bhattacharya, A., and Montgomery, O. (2010). Human
Papillomavirus and Cervical Cancer Knowledge, Health Beliefs, and Preventative Practices in
Older Women. Journal of Obstetrics, Gynecology and Neonatal Nursing, 39(3): 238 – 249.
Mosavel, M. and El-Shaarawi, N. (2007). “I Have Never Heard That One”: Young Girls’
Knowledge and Perception of Cervical Cancer. Journal of Health Communication, 12: 707 –
719.
Moyer, V.A. (2012). Screening for Cervical Cancer: U.S. Preventive Services Task Force
Recommendation Statement. Annals of Internal Medicine, 156(12): 880 – 891.
Nardi, C., Sandhu, P., and Selix, N. (2016). Cervical Cancer Screening among Minorities in the
United States. The Journal for Nurse Practitioners, 12(10): 675 – 682.

102

Nolan, J., Renderos, T.B., Hynson, J., Dai, S., Chow, W., Christie, A., and Mangione, T.W.
(2014). Barriers to Cervical Cancer Screening and Follow-Up Care among Black Women in
Massachusetts. Journal of Obstetrics, Gynecology and Neonatal Nursing, 43(5): 580 – 588.
Nonzee, N.J., Ragas, D.M., Luu, T.H., Phisuthikul, A.M., Tom, L., Dong, X.Q., and Simon,
M.A. (2015). Delays in Cancer Care among Low-Income Minorities Despite Access. Journal of
Women’s Health, 24(6): 506 – 514.
Ogunwale, A.N., Coleman, M.A., Sangi-Haghpeykar, H., Valverde, I., Montealegre, J., JibajaWeiss, M., and Anderson, M.L. (2016). Assessment of Factors Impacting Cervical Cancer
Screening among Low-Income Women Living with HIV-AIDS. AIDS Care, 28(4): 491 – 494.
Peralta, A.M., Holaday, B., and Hadoto, I.M. (2017). Cues to Cervical Cancer Screening among
U.S. Hispanic Women. Hispanic Health Care International, 15(1): 5 – 12.
Perry, B.L., Harp, K.L.H., and Oser, C.B. (2013). Racial and Gender Discrimination in the Stress
Process: Implications for African American Women’s Health and Well-Being. Sociological
Perspectives, 56(1): 25 – 48.
Phillips, D.Y., Walsh, B., Bullion, J.W., Reid, P.V., Bacon, K., and Okoro, N. (2014). The
Intersection of Intimate Partner Violence and HIV in U.S. Women: A Review. Journal of the
Association of Nurses in AIDS Care, 25(1S): S36 – S49.
Pichon, L.C., Morrell, K., Digney, S.A., Montgomery, M., and Asemota, A. (2012). The 2012
Memphis Transitional Grant Area (TGA) Ryan White Part A Comprehensive Needs Assessment.
Memphis, TN; The University of Memphis School of Public Health, Memphis TGA Ryan White
Part A Program, Shelby County Health Department Epidemiology Section.
Potter, E.C., Allen, K.R., and Roberto, K.A. (2018). Agency and Fatalism in Older Appalachian
Women’s Information Seeking about Gynecological Cancer. Journal of Women and Aging, DOI:
https://doi.org/10.1080/08952841.2018.1434951.
Prado, G., Feaster, D.J., Schwartz, S.J., Pratt, I.A., Smith, L., and Szapocznik, J. (2004).
Religious Involvement, Coping, Social Support, and Psychological Distress in HIV-Seropositive
African American Mothers. AIDS and Behavior, 8(3): 221 – 235.
Rahangdale, L., Samquist, C., Yavari, A., Blumenthal, P., and Israelski, D. (2010). Frequency of
Cervical Cancer and Breast Cancer Screening in HIV-Infected Women in a County-Based HIV
Clinic in the Western United States. Journal of Women’s Health, 19(4): 709 – 712.
Raiford, J.L., Wingood, G.M., and DiClemente, R.J. (2007). Correlates of Consistent Condom
Use among HIV-Positive African American Women. Women & Health, 46(2/3): 41 – 58.

103

Rao, D., Andrasik, M.P., and Lipira, L. (2018). HIV Stigma among Black Women in the United
States: Intersectionality, Support, Resilience. American Journal of Public Health, 108(4): 446 –
448.
Saghari, S., Ghamsary, M., Marie-Mitchell, A., Oda, K., and Morgan, J.W. (2015).
Sociodemographic Predictors of Delayed versus Early Stage Cervical Cancer in California.
Annals of Epidemiology, 25: 250 – 255.
Schlect, N.F., Burk, R.D., Palefsky, J.M., Minkoff, H., Xue, X., Massad, L.S., Bacon, M.,
Levine, A.M., Anastos, K., Gange, S.J., Watts, H., Da Costa, M.M., Chen, Z., Bang, J.Y.,
Fazzari, M., Hall, C., and Strickler, H.D. (2006). Variants of Human Papillomavirus 16 and 18
and Their Natural History in Human Immunodeficiency Virus-Positive Women. Journal of
General Virology, 86: 2709 – 2020.
Sharpe, P.A., Brandt, H.M., and McCree, D.H. (2006). Knowledge and Beliefs about Abnormal
Pap Test Results and HPV among Women with High-Risk HPV: Results from In-Depth
Interviews. Women & Health, 42(2): 107 – 133.
Silva, I.T., Griep, R.H., and Rotenberg, L. (2009). Social Support and Cervical and Breast
Cancer Screening Practices among Nurses. Revista Latino-Americana de Enfermagem 17: 514 –
521.
Silverberg, M.J., Schneider, M.F., Silver, B., Anastos, K.M., Burk, R.D., Minkoff, H., Palefsky,
J., Levine, A.M., and Viscidi, R.P. (2006). Serological Detection of Human Papillomavirus Type
16 Infection in Human Immunodeficiency Virus (HIV)-Positive and High-Risk HIV-Negative
Women. Clinical and Vaccine Immunology, 13(4): 511 – 519.
Slomka, J., Lim, J.W., Gripshover, B., and Daly, B. (2013). How Have Long-Term Survivors
Coped with Living with HIV? Journal of the Association of Nurses in AIDS Care, 24(5): 449 –
459.
Smeltzer, S., Yu, X., Schmeler, K., and Levison, J. (2016). Abnormal Vaginal Pap Test Results
after Hysterectomy in Human Immunodeficiency Virus-Infected Women. Obstetrics and
Gynecology, 128(1): 52 – 57.
Starks, H. and Brown Trinidad, S. (2007). Choose Your Method: A Comparison of
Phenomenology, Discourse Analysis and Grounded Theory. Qualitative Health Research,
17(10): 1372 – 1380.
Steele-Moses, S.K., Russell, K.M., Kreuter, M., Monahan, P., Bourff, S., and Champion, V.L.
(2009). Cultural Constructs, Stage of Change, and Adherence to Mammography among LowIncome African American Women. Journal of Health Care for the Poor and Underserved,
20(1): 257 – 273.

104

Steward, W.T., Koester, K.A., Myers, J.J., and Morin, S.F. (2006). Provider Fatalism Reduces
the Likelihood of HIV-Prevention Counseling in Primary Care Settings. AIDS and Behavior,
10(1): 3 – 12.
Stokols, D. (1996). Translating Social Ecological Theory into Guidelines for Community Health
Promotion. American Journal of Health Promotion, 10(4): 282 – 298.
Studts, C.R., Tarasenko, Y.N., and Schoenberg, N.E. (2013). Barriers to Cervical Cancer
Screening among Middle-Aged and Older Rural Appalachian Women. Journal of Community
Health, 38: 500 – 512.
Szaflarski, M. (2013). Spirituality and Religion among HIV-Infected Individuals. Current
HIV/AIDS Reports, 10(4): 324 – 332.
Tanner-Smith, E.E. and Brown, T.N. (2010). Evaluating the Health Belief Model: A Critical
Review of Studies Predicting Mammographic and Pap Screening. Social Theory and Health,
8(1): 95 – 125.
Tello, M.A., Jenckes, M., Gaver, J., Anderson, J.R., Moore, R.D., and Chandler, G. (2010).
Barriers to Recommended Gynecologic Care in an Urban United States HIV Clinic. Journal of
Women’s Health, 19(8): 1511 – 1518.
Valente, T.W. (2012). Network Interventions. Science, 337(6): 49 – 53.
Vanderpool, R.C., Dressler, E.V.M., Stradtman, L.R., and Crosby, R.A. (2015). Fatalistic Beliefs
and Completion of the HPV Vaccination Series among a Sample of Young Appalachian
Kentucky Women. Journal of Rural Health, 31: 199 – 205.
Vu, M., Azmat, A., Radejko, T., and Padela, A.I. (2016). Predictors of Delayed Healthcare
Seeking among American Muslim Women. Journal of Women’s Health, 25(6): 586 – 593.
Vyas, K.J., Limneos, J., Qin, H., and Mathews, W.C. (2014). Assessing Baseline Religious
Practices and Beliefs to Predict Adherence to Highly Active Antiretroviral Therapy among HIVInfected Persons. AIDS Care, 26(8): 983 – 987.
Vyavaharkar, M., Moneyham, L., Corwin, S., Saunders, R., Annang, L., and Tavakoli, A.
(2010). Relationships Between Stigma, Social Support, and Depression in HIV-Infected African
American Women Living in the Rural Southeastern United States. Journal of the Association of
Nurses in AIDS Care, 21(2): 144 – 152.
Walker, D. and Myrick, F. (2006). Grounded Theory: An Exploration of Process and Procedure.
Qualitative Health Research, 16(4): 547 – 559.

105

Wigfall, L., Rawls, A., Sebastian, N., Messersmith, A., Pirisi-Creek, L., Spiryda, L., Williams,
E.M., Creek, K., and Glover, S.H. (2012). HPV High Risk and Protective Behaviors: The Effects
of Religious Affiliation. Journal of Religion and Health, 51: 1325 – 1336.
Wigfall, L.T., Bynum, S.A., Friedman, D.B., Brandt, H.M., Richter, D.L., Glover, S.H., and
Hebert, J.R. (2017). Patient-Provider Communication with HIV-Positive Women about
Abnormal Pap Test Results. Women and Health, 57(1): 19 – 39.
Williams, M., Moneyham, L., Kempf, M.C., Chamot, E., and Scarinci, I. (2015). Structural and
Sociocultural Factors Associated with Cervical Cancer Screening among HIV-Infected African
American Women in Alabama. AIDS Patient Care and STDs, 29(1): 13 – 19.
Williamson, T.J., Mahmood, Z., Kuhn, T.P., and Thames, A.D. (2017). Differential
Relationships Between Social Adversity and Depressive Symptoms by HIV Status and Racial/
Ethnic Identity. Health Psychology, 36(2): 133 – 142.
Wong, J.P.H., Vahabi, M., Miholjcic, J., Tan, V., Owino, M., Li, A.T.W., and Poon, M.K.L.
(2018). Knowledge of HPV/ Cervical Cancer and Acceptability of HPV Self-Sampling among
Women Living with HIV: A Scoping Review. Current Oncology, 25(1): e73 – e82.
Yoo, W., Kim, S., Huh, W.K., Dilley, S., Coughlin, S.S., Partridge, E.E., Chung, Y., Dicks, V.,
Lee, J.K., and Bae, S. (2017). Recent Trends in Racial and Regional Disparities in Cervical
Cancer Incidence and Mortality in United States. PLoS ONE, 12(2): 1 – 13.

106

APPENDIX A: RECRUITMENT FLYER

107

APPENDIX B: INTERVIEW GUIDE
A Pap smear is a common procedure for cervical cancer screening in women. It is performed by
a gynecologist and involves a small brush that scrapes cells off a woman’s cervix to test them for
any abnormalities. You’re here today to talk about your thoughts and experiences with Pap
smears. There are no right or wrong answers, your opinion is what matters to me, so please feel
free to share whatever you are comfortable with sharing. I’ll be recording our discussion today,
but everything you say will be kept private and your identity will not be revealed. This
discussion should take around an hour and you’ll receive a $10 Kroger gift card for your
participation. Do you have any questions or concerns before we get started?
 Tell me about your experience(s) with Pap test screening.
o How has having HIV affected your decisions about getting a Pap smear?
o What are your feelings about getting a Pap smear?
o What is a Pap smear?
o What is getting a Pap smear like for you?
o Have you ever had a bad experience getting a Pap smear?


As best you can recall, describe step-by-step your last Pap smear appointment.
o How did you schedule the appointment?
o How was it when you got to the appointment?
o What was the doctor like?
o How did you get the results?
o How was your last appointment compared to other appointments?



What do you think of your risk of getting cervical cancer?
o How much do you worry about getting cervical cancer?
o Is there anything you think puts you at more/less risk for cervical cancer?
o Why do you think some people might be at more/less risk for cervical cancer?



What do you think happens to someone who has an abnormal Pap smear?
o How would having an abnormal Pap affect you?
o What would it mean to you to have an abnormal Pap smear?



What do you think happens to someone with cervical cancer?
o How would you feel if you were diagnosed with cervical cancer?
o How would having cervical cancer affect you?
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What are the benefits of getting a Pap smear every year?
o Why would you get a Pap smear?
o What are some reasons you might decide to get a Pap smear?



What are the barriers to getting a Pap smear every year?
o Why would you not get a Pap smear?


What are some disadvantages to getting a Pap smear?



What are some things you worry about when getting a Pap smear?

o What are some things that make it hard for you to get a Pap smear?





What are some challenges you might face in getting a Pap smear?



Is there anything in particular that makes it difficult to get a Pap smear?

What are some cues that might help you get a Pap smear every year?
o What are some things that make it easy for you to get a Pap smear?
o Is there anything in particular that helps you get a Pap smear?
o Is there anything that triggers it’s time to get a Pap smear for you?



Who talks to you about cervical cancer screening? What do they say?
o Is there anyone who tells you or reminds you to get a Pap smear? If so, what do
they say?
o Who do you talk about ways to staying healthy? What do they say?
o Is there anyone who talks to you about preventative health behaviors, like
screening? If so, what do they say?



How do your religious or spiritual beliefs influence your cervical cancer screening
practices?
o What does your church tell you about getting an annual Pap smear?
o Why do you think churches don’t talk about Pap smears?
o In what ways does your church influence your beliefs about preventative
screenings?
o Does your church do health fairs or anything else to promote healthy behaviors?
Why or why not?
o How do your religious or spiritual beliefs influence your health?
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APPENDIX C: PARTICIPANT QUESTIONNAIRE
Instructions: The following questions are about your background and health status.
1. How old are you?
(If not between ages 18 to 45 years old, stop interview.)
2. What is your gender? (If not Female with a Cervix, stop interview.)



Female with a Cervix



Male



Transgender



Other

3. What race do you most identify with? (If not Black or African American, stop interview).








Black or African American
White or Caucasian
Asian
American Indian or Alaska Native
Native Hawaiian or Pacific Islander
Other:

4. What is your ethnicity?



Hispanic/ Latino



Non-Hispanic/ Latino

5. What is your current relationship status?







Single
Steady Partner But Not Living Together
Married/ Living with Partner
Widowed
Separated/ Divorced

6. What county do you live in?











Shelby County, TN
Fayette County, TN
Tipton County, TN
Desoto County, MS
Tunica County, MS
Tate County, MS
Marshall County, MS
Crittenden County, AR
Other:
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7. What best describes your current living situation?









I own the home I live in
I rent the home I live in
I am staying with family/ friends
I live in a car or other vehicle
I live in a shelter
I live on the streets
Other:

8. What is the highest level of school you have completed?







Less than High School
High School or GED
Some College or Vocational School
College Graduate (Bachelors Degree)
Graduate Degree (Masters, Doctorate, MD, PhD)

9. What is your current job situation?










Working Full-Time
Working Part-Time
Working Off and On
Unemployed (Looking for Work)
Unemployed (Not Looking for Work)
Homemaker
Student
Other:

10. What is your annual household income?







$0 - $5,000
$5,001 - $10,000
$10,001 - $15,000
$15,001 - $20,000
$20,001 - $30,000
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$30,001 - $40,000
$40,001 - $50,000
$50,001 - $60,000
$60,001 or Higher

11. What religion do you most identify with?










Baptist
Catholic
Church of God in Christ
(COGIC)

Disciples of Christ (DOC)
Non-Denominational
Agnostic/ Atheist
Other:

12. How important would you say religion is in your life?






Not at all important
A little important
Somewhat important
Very important

13. Have you ever been diagnosed with HIV? (If No or Don’t Know, stop interview.)



Yes





No

Don’t Know

14. What year were you first diagnosed with HIV?
15. How soon after you were diagnosed with HIV did you go to see a doctor about your HIV
diagnosis?









Immediately
Within 6 Months
Within a Year
Longer than 1 Year
I Have Not Seen a Doctor for HIV
Don’t Remember
Other:

16. Have you ever been diagnosed with AIDS?



Yes





No

Don’t Know

17. Have you had any of the following in the last 12 months?





CD4 Counts (If yes, what was it?
Viral Load Test (If yes, what was it?
HIV Medication (ARV)
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)
)

18. How often have you received HIV care in the past 12 months?







I have not been to an HIV care visit in the past 12 months
1 Time
2 Times
3 Times
4 or More Times

19. What type of health insurance do you have?








Private
Medicaid/ TennCare

No Insurance
Other:

Medicare

20. Do you participate in the Ryan White program?



Yes





No

Don’t Know

21. Have you had a Pap smear in the past 3 years? (If No or Don’t Know, stop interview.)



Yes



No



Don’t Know



Don’t Know

22. What year was your last Pap smear?
23. Have you ever had an abnormal Pap smear?



Yes



No

24. How soon after your abnormal Pap smear did you follow-up with a doctor?









Immediately
Within 6 Months
Within a Year
Longer than 1 Year
I Have Not Seen a Doctor for Follow-Up
Don’t Remember
Other:

25. Have you ever…?
Yes

a. Been diagnosed with HPV
b. Been diagnosed with pre-cancer cells in your cervix
c. Been diagnosed with cervical cancer
d. Received an HPV vaccine, such as Gardasil or Cervavix
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No

Don’t Know

Instructions: The following questions about Pap test screening. Indicate whether each
statement is true or false. (Interviewer: Read each statement and place a check mark or an X in
the box beside the answer the participant thinks is correct.)
1. The purpose of the Pap smear test is to:
True
False Don’t Know
a. Check your ovaries
b. Scrape cells to look for cancer
c. Treat cancer
d. Test for sexual disease
e. Check your urine
2. Symptoms of an abnormal Pap smear are:
True
False Don’t Know
a. Vaginal itching/ irritation
b. Pain with sexual intercourse
c. A frequent need to urinate
d. Unnoticeable/ no symptoms
e. Unusual vaginal spotting/ bleeding
f. Genital warts
3. If you have an abnormal result on the Pap test:
True
False Don’t Know
a. You should tell your partner
b. It means you have cancer
c. The problem could go away on its own
d. You may need more frequent Pap smears
4. Follow-up for an abnormal Pap smear can involve:
True
False Don’t Know
a. A blood test
b. Biopsy
c. Another Pap smear test
d. Colposcopy
e. HPV testing
Thank you!
For Internal Use Only:
Interviewer Initials:
Gift Card #:
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APPENDIX D: ELIGIBILITY SCREENING TOOL
Unique Identifier:
Date:

Thank you for calling about the Pap smear study. Let’s make sure you’re eligible to participate.
1. How old are you?
(Exclude if <18 or >45 years old*)
2. What is your gender?





Female with a Cervix
(Exclude*)



Male (Exclude*)

Transgender

3. What race do you most identify with?








Black or African American
White or Caucasian (Exclude*)
Asian (Exclude*)
American Indian or Alaska Native (Exclude*)
Native Hawaiian or Pacific Islander (Exclude*)
Other:

(Exclude if not Black/ African American*)

4. Have you ever been diagnosed with HIV?





Yes

No (Exclude*)



Don’t Know (Exclude*)

5. Have you ever had a Pap smear in the past 3 years?



Yes
 No (Exclude*)
 Don’t Know (Exclude*)
*[Exclusion Script]: I am sorry, but you need to
to participate. Thank you for
your interest in this research study. Do you have any questions?
[If eligible]: Great, you are eligible to participate in this study! Let’s get your interview
scheduled.
Interview Date:
Interview Time:
Interview Location:
Participant’s Contact #:
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APPENDIX E: INFORMED CONSENT FORM
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APPENDIX F: CERVICAL CANCER BROCHURE
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APPENDIX G: GENITAL HPV INFECTION FACT SHEET
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